Advanced Search (OLGA)

Gene: VGLL3 (vestigial like family member 3) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

VGLL3

Name:

vestigial like family member 3

RGD ID:

1602804

HGNC Page

HGNC:24327

Description:

Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Type:

protein-coding

RefSeq Status:

VALIDATED

Previously known as:

colon carcinoma related protein; DKFZp686O1845; FLJ38507; transcription cofactor vestigial-like protein 3; vestigial like 3; vestigial-like 3; vestigial-like family member 3; VGL-3; VGL3

RGD Orthologs

Alliance Orthologs

More Info

more info ...

More Info

Species	Gene symbol and name	Data Source	Assertion derived from	less info ...
Orthologs ¹				less info ...
Mus musculus (house mouse):	Vgll3 (vestigial like family member 3)	HGNC	EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, Treefam
Rattus norvegicus (Norway rat):	Vgll3 (vestigial-like family member 3)	HGNC	EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Chinchilla lanigera (long-tailed chinchilla):	Vgll3 (vestigial like family member 3)	NCBI	Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):	VGLL3 (vestigial like family member 3)	NCBI	Ortholog
Canis lupus familiaris (dog):	VGLL3 (vestigial like family member 3)	HGNC	EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):	Vgll3 (vestigial like family member 3)	NCBI	Ortholog
Sus scrofa (pig):	VGLL3 (vestigial like family member 3)	HGNC	Ensembl, Inparanoid, NCBI, OrthoDB
Chlorocebus sabaeus (green monkey):	VGLL3 (vestigial like family member 3)	NCBI	Ortholog
Heterocephalus glaber (naked mole-rat):	Vgll3 (vestigial like family member 3)	NCBI	Ortholog
Other homologs ²
Rattus norvegicus (Norway rat):	Gbe1 (1,4-alpha-glucan branching enzyme 1)	HGNC	OMA
Alliance orthologs ³
Rattus norvegicus (Norway rat):	Vgll3 (vestigial-like family member 3)	Alliance	DIOPT (Ensembl Compara\|HGNC\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Mus musculus (house mouse):	Vgll3 (vestigial like family member 3)	Alliance	DIOPT (HGNC\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Danio rerio (zebrafish):	vgll3 (vestigial-like family member 3)	Alliance	DIOPT (Ensembl Compara\|Hieranoid\|InParanoid\|OrthoFinder\|OrthoInspector\|PANTHER\|SonicParanoid\|ZFIN)
Drosophila melanogaster (fruit fly):	vg	Alliance	DIOPT (Ensembl Compara\|OrthoFinder\|OrthoInspector\|PANTHER\|SonicParanoid)
Xenopus laevis (African clawed frog):	vgll3.L	Alliance	DIOPT (Xenbase)
Xenopus tropicalis (tropical clawed frog):	vgll3	Alliance	DIOPT (Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER)

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	3	86,937,973 - 86,991,149 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	3	86,876,388 - 86,991,149 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	3	86,987,123 - 87,040,299 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	3	87,069,813 - 87,122,947 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Celera	3	87,739,047 - 87,793,404 (-)	NCBI		Celera
Cytogenetic Map	3	p12.1	NCBI
HuRef	3	87,000,438 - 87,053,543 (-)	NCBI		HuRef
CHM1_1	3	86,939,749 - 86,992,814 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	3	87,012,305 - 87,065,510 (-)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
VGLL3	Human	1,2-dichloroethane	decreases expression	ISO	RGD:1618297	6480464	ethylene dichloride results in decreased expression of VGLL3 mRNA	CTD	PMID:28960355
VGLL3	Human	1,2-dimethylhydrazine	increases expression	ISO	RGD:1618297	6480464	1,2-Dimethylhydrazine results in increased expression of VGLL3 mRNA	CTD	PMID:22206623
VGLL3	Human	17beta-estradiol	affects expression	EXP		6480464	Estradiol affects the expression of VGLL3 mRNA	CTD	PMID:22574217
VGLL3	Human	17beta-estradiol	increases expression	ISO	RGD:1618297	6480464	Estradiol results in increased expression of VGLL3 mRNA	CTD	PMID:19484750
VGLL3	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1560030	6480464	Tetrachlorodibenzodioxin results in increased expression of VGLL3 mRNA	CTD	PMID:34747641
VGLL3	Human	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1560030	6480464	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of VGLL3 mRNA	CTD	PMID:32109520
VGLL3	Human	2-hydroxypropanoic acid	decreases expression	EXP		6480464	Lactic Acid results in decreased expression of VGLL3 mRNA	CTD	PMID:30851411
VGLL3	Human	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1618297	6480464	tetrabromobisphenol A results in decreased expression of VGLL3 mRNA	CTD	PMID:25172293
VGLL3	Human	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1618297	6480464	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of VGLL3 mRNA	CTD	PMID:20188158
VGLL3	Human	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ...	CTD	PMID:28628672
VGLL3	Human	4,4'-sulfonyldiphenol	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] more ...	CTD	PMID:28628672
VGLL3	Human	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1618297	6480464	bisphenol S results in increased expression of VGLL3 mRNA	CTD	PMID:30951980
VGLL3	Human	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1618297	6480464	Fenretinide results in decreased expression of VGLL3 mRNA	CTD	PMID:28973697
VGLL3	Human	8-Br-cAMP	decreases expression	EXP		6480464	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of VGLL3 mRNA	CTD	PMID:20147733
VGLL3	Human	aflatoxin B1	affects expression	EXP		6480464	Aflatoxin B1 affects the expression of VGLL3 protein	CTD	PMID:20106945
VGLL3	Human	all-trans-retinoic acid	decreases expression	EXP		6480464	Tretinoin results in decreased expression of VGLL3 mRNA	CTD	PMID:21934132
VGLL3	Human	benzo[a]pyrene	decreases methylation	EXP		6480464	Benzo(a)pyrene results in decreased methylation of VGLL3 promoter	CTD	PMID:27901495
VGLL3	Human	benzo[a]pyrene	increases expression	EXP		6480464	Benzo(a)pyrene results in increased expression of VGLL3 mRNA	CTD	PMID:32234424
VGLL3	Human	bis(2-ethylhexyl) phthalate	increases expression	EXP		6480464	Diethylhexyl Phthalate results in increased expression of VGLL3 mRNA	CTD	PMID:31163220
VGLL3	Human	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1618297	6480464	Diethylhexyl Phthalate results in decreased expression of VGLL3 mRNA	CTD	PMID:34319233
VGLL3	Human	bisphenol A	affects expression	ISO	RGD:1560030	6480464	bisphenol A affects the expression of VGLL3 mRNA	CTD	PMID:25181051
VGLL3	Human	bisphenol A	multiple interactions	EXP		6480464	[bisphenol A co-treated with Fulvestrant] results in increased methylation of VGLL3 gene	CTD	PMID:31601247
VGLL3	Human	bisphenol A	decreases expression	EXP		6480464	bisphenol A results in decreased expression of VGLL3 mRNA	CTD	PMID:29275510
VGLL3	Human	bisphenol A	increases expression	ISO	RGD:1618297	6480464	bisphenol A results in increased expression of VGLL3 mRNA	CTD	PMID:30951980
VGLL3	Human	bisphenol F	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ...	CTD	PMID:28628672
VGLL3	Human	bisphenol F	increases expression	ISO	RGD:1618297	6480464	bisphenol F results in increased expression of VGLL3 mRNA	CTD	PMID:30951980
VGLL3	Human	butanal	decreases expression	EXP		6480464	butyraldehyde results in decreased expression of VGLL3 mRNA	CTD	PMID:26079696
VGLL3	Human	cadmium atom	multiple interactions	EXP		6480464	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of VGLL3 more ...	CTD	PMID:35301059
VGLL3	Human	cadmium dichloride	increases expression	EXP		6480464	Cadmium Chloride results in increased expression of VGLL3 mRNA	CTD	PMID:38382870
VGLL3	Human	cadmium dichloride	multiple interactions	EXP		6480464	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of VGLL3 more ...	CTD	PMID:35301059
VGLL3	Human	chloroprene	decreases expression	ISO	RGD:1618297	6480464	Chloroprene results in decreased expression of VGLL3 mRNA	CTD	PMID:23125180
VGLL3	Human	cisplatin	multiple interactions	EXP		6480464	[Cisplatin co-treated with jinfukang] results in decreased expression of VGLL3 mRNA	CTD	PMID:27392435
VGLL3	Human	cyclosporin A	decreases expression	EXP		6480464	Cyclosporine results in decreased expression of VGLL3 mRNA	CTD	PMID:20106945
VGLL3	Human	dexamethasone	increases expression	EXP		6480464	Dexamethasone results in increased expression of VGLL3 mRNA	CTD	PMID:25047013
VGLL3	Human	dexamethasone	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ...	CTD	PMID:28628672
VGLL3	Human	dibutyl phthalate	increases expression	ISO	RGD:1618297	6480464	Dibutyl Phthalate results in increased expression of VGLL3 mRNA	CTD	PMID:21266533
VGLL3	Human	dimethylarsinous acid	increases expression	EXP		6480464	dimethylarsinous acid results in increased expression of VGLL3 mRNA	CTD	PMID:23876855
VGLL3	Human	dioxygen	multiple interactions	ISO	RGD:1618297	6480464	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of VGLL3 mRNA	CTD	PMID:30529165
VGLL3	Human	dorsomorphin	multiple interactions	EXP		6480464	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...	CTD	PMID:27188386
VGLL3	Human	enniatin	increases expression	EXP		6480464	enniatins results in increased expression of VGLL3 mRNA	CTD	PMID:36016515
VGLL3	Human	entinostat	increases expression	EXP		6480464	entinostat results in increased expression of VGLL3 mRNA	CTD	PMID:26272509
VGLL3	Human	entinostat	multiple interactions	EXP		6480464	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...	CTD	PMID:27188386
VGLL3	Human	epoxiconazole	increases expression	ISO	RGD:1618297	6480464	epoxiconazole results in increased expression of VGLL3 mRNA	CTD	PMID:35436446
VGLL3	Human	fenamidone	increases expression	ISO	RGD:1618297	6480464	fenamidone results in increased expression of VGLL3 mRNA	CTD	PMID:27029645
VGLL3	Human	folic acid	affects expression	EXP		6480464	Folic Acid affects the expression of VGLL3 mRNA	CTD	PMID:17320366
VGLL3	Human	folic acid	increases expression	ISO	RGD:1618297	6480464	Folic Acid results in increased expression of VGLL3 mRNA	CTD	PMID:25629700
VGLL3	Human	fulvestrant	multiple interactions	EXP		6480464	[bisphenol A co-treated with Fulvestrant] results in increased methylation of VGLL3 gene	CTD	PMID:31601247
VGLL3	Human	genistein	decreases expression	ISO	RGD:1618297	6480464	Genistein results in decreased expression of VGLL3 mRNA	CTD	PMID:32186404
VGLL3	Human	indometacin	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ...	CTD	PMID:28628672
VGLL3	Human	isoprenaline	increases expression	ISO	RGD:1618297	6480464	Isoproterenol results in increased expression of VGLL3 mRNA	CTD	PMID:20003209
VGLL3	Human	ketoconazole	decreases expression	EXP		6480464	Ketoconazole results in decreased expression of VGLL3 mRNA	CTD	PMID:36621641
VGLL3	Human	lead diacetate	decreases expression	ISO	RGD:1560030	6480464	lead acetate results in decreased expression of VGLL3 mRNA	CTD	PMID:22641619
VGLL3	Human	lead(0)	affects expression	EXP		6480464	Lead affects the expression of VGLL3 mRNA	CTD	PMID:28903495
VGLL3	Human	lipopolysaccharide	multiple interactions	EXP		6480464	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of VGLL3 mRNA	CTD	PMID:35811015
VGLL3	Human	mercury dibromide	increases expression	EXP		6480464	mercuric bromide results in increased expression of VGLL3 mRNA	CTD	PMID:26272509
VGLL3	Human	mercury dibromide	multiple interactions	EXP		6480464	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...	CTD	PMID:27188386
VGLL3	Human	methoxychlor	affects methylation	ISO	RGD:1560030	6480464	Methoxychlor affects the methylation of VGLL3 gene	CTD	PMID:35440735
VGLL3	Human	methylmercury chloride	increases expression	EXP		6480464	methylmercuric chloride results in increased expression of VGLL3 mRNA	CTD	PMID:23179753\|PMID:26272509
VGLL3	Human	nitrofen	decreases expression	ISO	RGD:1560030	6480464	nitrofen results in decreased expression of VGLL3 mRNA	CTD	PMID:33484710
VGLL3	Human	panobinostat	increases expression	EXP		6480464	panobinostat results in increased expression of VGLL3 mRNA	CTD	PMID:26272509
VGLL3	Human	panobinostat	multiple interactions	EXP		6480464	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...	CTD	PMID:27188386
VGLL3	Human	paracetamol	increases expression	ISO	RGD:1560030	6480464	Acetaminophen results in increased expression of VGLL3 mRNA	CTD	PMID:33387578
VGLL3	Human	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1618297	6480464	perfluorooctane sulfonic acid affects the expression of VGLL3 mRNA	CTD	PMID:19429403
VGLL3	Human	perfluorooctanoic acid	affects expression	ISO	RGD:1618297	6480464	perfluorooctanoic acid affects the expression of VGLL3 mRNA	CTD	PMID:19429403
VGLL3	Human	permethrin	increases expression	EXP		6480464	Permethrin results in increased expression of VGLL3 mRNA	CTD	PMID:37047231
VGLL3	Human	phenylmercury acetate	increases expression	EXP		6480464	Phenylmercuric Acetate results in increased expression of VGLL3 mRNA	CTD	PMID:26272509
VGLL3	Human	phenylmercury acetate	multiple interactions	EXP		6480464	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...	CTD	PMID:27188386
VGLL3	Human	rac-lactic acid	decreases expression	EXP		6480464	Lactic Acid results in decreased expression of VGLL3 mRNA	CTD	PMID:30851411
VGLL3	Human	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		6480464	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of VGLL3 mRNA	CTD	PMID:35811015
VGLL3	Human	SB 431542	multiple interactions	EXP		6480464	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...	CTD	PMID:27188386
VGLL3	Human	silicon dioxide	decreases expression	EXP		6480464	Silicon Dioxide analog results in decreased expression of VGLL3 mRNA	CTD	PMID:25895662
VGLL3	Human	sodium arsenite	decreases expression	EXP		6480464	sodium arsenite results in decreased expression of VGLL3 mRNA	CTD	PMID:25879800\|PMID:34032870\|PMID:35954277
VGLL3	Human	sodium arsenite	decreases expression	ISO	RGD:1618297	6480464	sodium arsenite results in decreased expression of VGLL3 mRNA	CTD	PMID:37682722
VGLL3	Human	sulforaphane	decreases expression	EXP		6480464	sulforaphane results in decreased expression of VGLL3 mRNA	CTD	PMID:31838189
VGLL3	Human	temozolomide	decreases expression	EXP		6480464	Temozolomide results in decreased expression of VGLL3 mRNA	CTD	PMID:31758290
VGLL3	Human	tetrachloromethane	affects expression	ISO	RGD:1618297	6480464	Carbon Tetrachloride affects the expression of VGLL3 mRNA	CTD	PMID:17484886
VGLL3	Human	thiram	increases expression	EXP		6480464	Thiram results in increased expression of VGLL3 mRNA	CTD	PMID:38568856
VGLL3	Human	titanium dioxide	decreases expression	ISO	RGD:1618297	6480464	titanium dioxide results in decreased expression of VGLL3 mRNA	CTD	PMID:23557971\|PMID:27760801
VGLL3	Human	titanium dioxide	decreases methylation	ISO	RGD:1618297	6480464	titanium dioxide results in decreased methylation of VGLL3 promoter	CTD	PMID:35295148
VGLL3	Human	trichostatin A	increases expression	EXP		6480464	trichostatin A results in increased expression of VGLL3 mRNA	CTD	PMID:24935251\|PMID:26272509
VGLL3	Human	trichostatin A	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...	CTD	PMID:27188386
VGLL3	Human	valproic acid	affects expression	EXP		6480464	Valproic Acid affects the expression of VGLL3 mRNA	CTD	PMID:25979313
VGLL3	Human	valproic acid	increases expression	EXP		6480464	Valproic Acid results in increased expression of VGLL3 mRNA	CTD	PMID:23179753\|PMID:24383497\|PMID:24935251\|PMID:26272509\|PMID:28001369
VGLL3	Human	valproic acid	decreases expression	EXP		6480464	Valproic Acid results in decreased expression of VGLL3 mRNA	CTD	PMID:23179753\|PMID:27188386
VGLL3	Human	valproic acid	multiple interactions	EXP		6480464	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...	CTD	PMID:27188386
VGLL3	Human	vorinostat	increases expression	EXP		6480464	vorinostat results in increased expression of VGLL3 mRNA	CTD	PMID:26272509

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
VGLL3	Human	regulation of DNA-templated transcription	involved_in	IEA	InterPro:IPR011520	150520179		InterPro	GO_REF:0000002
VGLL3	Human	regulation of transcription by RNA polymerase II	involved_in	IBA	FB:FBgn0003975\|MGI:2447460\|PANTHER:PTN000409396	150520179		GO_Central	GO_REF:0000033

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
VGLL3	Human	nucleus	located_in	IEA	UniProtKB-SubCell:SL-0191	150520179		UniProt	GO_REF:0000044
VGLL3	Human	nucleus	is_active_in	IBA	FB:FBgn0003975\|MGI:2447460\|PANTHER:PTN000409396\|UniProtKB:Q99990	150520179		GO_Central	GO_REF:0000033
VGLL3	Human	nucleus	located_in	IEA	InterPro:IPR011520	150520179		InterPro	GO_REF:0000002
VGLL3	Human	nucleus	located_in	IEA	UniProtKB-KW:KW-0539	150520179		UniProt	GO_REF:0000043

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
VGLL3	Human	protein binding	enables	IPI	UniProtKB:A1KXE4-2\|UniProtKB:A8MQ03\|UniProtKB:O14817\|UniProtKB:O14964\|UniProtKB:O15496\|UniProtKB:O43559\|UniProtKB:P28347-2\|UniProtKB:P59990\|UniProtKB:P59991\|UniProtKB:P60328\|UniProtKB:P60409\|UniProtKB:P60410\|UniProtKB:P60411\|UniProtKB:P78337\|UniProtKB:Q07627\|UniProtKB:Q0VD86\|UniProtKB:Q14847-2\|UniProtKB:Q15561\|UniProtKB:Q15562-2\|UniProtKB:Q16633\|UniProtKB:Q3LHN2\|UniProtKB:Q3LI64\|UniProtKB:Q3LI66\|UniProtKB:Q3LI70\|UniProtKB:Q3LI76\|UniProtKB:Q3SYF9\|UniProtKB:Q52LG2\|UniProtKB:Q5T4B2\|UniProtKB:Q5T749\|UniProtKB:Q6L8G4\|UniProtKB:Q6L8G9\|UniProtKB:Q6NVU6\|UniProtKB:Q6NVV7\|UniProtKB:Q7Z3K3\|UniProtKB:Q86UW9\|UniProtKB:Q86WV8\|UniProtKB:Q8IUB9\|UniProtKB:Q8IUC1\|UniProtKB:Q8IWZ5\|UniProtKB:Q8TDS5\|UniProtKB:Q92824-2\|UniProtKB:Q92922\|UniProtKB:Q93062-3\|UniProtKB:Q96JP2\|UniProtKB:Q96LM6\|UniProtKB:Q96PV6\|UniProtKB:Q96SF7\|UniProtKB:Q99594\|UniProtKB:Q99697-2\|UniProtKB:Q99750\|UniProtKB:Q99895\|UniProtKB:Q9BVN2\|UniProtKB:Q9BYD5\|UniProtKB:Q9BYQ0\|UniProtKB:Q9BYQ3\|UniProtKB:Q9BYQ4\|UniProtKB:Q9BYQ6\|UniProtKB:Q9BYR5\|UniProtKB:Q9BYR6\|UniProtKB:Q9BYR8\|UniProtKB:Q9H4F8-2\|UniProtKB:Q9NQ30	150520179	PMID:32296183	IntAct	PMID:32296183

#	Reference Title	Reference Citation
1.	ClinVar Automated Import and Annotation Pipeline	RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
2.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions

PMID:11819507	PMID:12376544	PMID:12477932	PMID:14702039	PMID:15146197	PMID:16344560	PMID:19336002	PMID:20842732	PMID:21102462	PMID:21873635	PMID:22219177	PMID:23152581
PMID:23251661	PMID:23415753	PMID:23449627	PMID:26618866	PMID:26972000	PMID:27992404	PMID:29180619	PMID:31138678	PMID:31992826	PMID:32296183	PMID:32385107	PMID:32803756
PMID:33060790	PMID:33649458	PMID:34679187	PMID:35198878	PMID:35256555	PMID:35434822	PMID:35559673	PMID:35766997	PMID:35941675	PMID:36754961	PMID:38348744

VGLL3
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	3	86,937,973 - 86,991,149 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	3	86,876,388 - 86,991,149 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	3	86,987,123 - 87,040,299 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	3	87,069,813 - 87,122,947 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Celera	3	87,739,047 - 87,793,404 (-)	NCBI		Celera
Cytogenetic Map	3	p12.1	NCBI
HuRef	3	87,000,438 - 87,053,543 (-)	NCBI		HuRef
CHM1_1	3	86,939,749 - 86,992,814 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	3	87,012,305 - 87,065,510 (-)	NCBI		T2T-CHM13v2.0

Vgll3
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	16	65,612,075 - 65,663,254 (+)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	16	65,612,143 - 65,663,254 (+)	Ensembl		GRCm39 Ensembl
GRCm38	16	65,815,189 - 65,866,368 (+)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	16	65,815,257 - 65,866,368 (+)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	16	65,815,878 - 65,863,311 (+)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	16	65,733,678 - 65,781,326 (+)	NCBI		MGSCv36	mm8
MGSCv36	16	66,265,561 - 66,314,128 (+)	NCBI		MGSCv36	mm8
Celera	16	66,081,364 - 66,128,723 (+)	NCBI		Celera
Cytogenetic Map	16	C1.3	NCBI
cM Map	16	37.34	NCBI

Vgll3
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	11	17,089,484 - 17,136,501 (+)	NCBI		GRCr8
mRatBN7.2	11	3,642,993 - 3,692,590 (+)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	11	3,643,069 - 3,689,140 (+)	Ensembl		mRatBN7.2 Ensembl
Rnor_6.0	11	3,119,509 - 3,168,883 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	11	3,119,885 - 3,164,751 (+)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	11	3,097,556 - 3,146,588 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	11	3,348,763 - 3,394,087 (+)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
Celera	11	3,617,060 - 3,666,333 (+)	NCBI		Celera
Cytogenetic Map	11	p12	NCBI

Vgll3
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955407	6,258,251 - 6,287,397 (+)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955407	6,247,557 - 6,293,133 (+)	NCBI	ChiLan1.0	ChiLan1.0

VGLL3
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	2	87,005,764 - 87,133,600 (-)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	3	87,087,730 - 87,138,166 (-)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	3	87,066,497 - 87,119,625 (-)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	3	89,183,186 - 89,233,290 (-)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	3	89,165,559 - 89,233,239 (-)	Ensembl	panpan1.1		panPan2

VGLL3
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	31	1,037,001 - 1,151,812 (+)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	31	1,036,652 - 1,143,670 (+)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	31	1,078,747 - 1,196,263 (+)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	31	1,020,681 - 1,138,576 (+)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	31	1,020,693 - 1,066,261 (+)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	31	999,127 - 1,046,551 (+)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	31	1,047,879 - 1,095,314 (+)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	31	1,350,874 - 1,468,572 (+)	NCBI		UU_Cfam_GSD_1.0

Vgll3
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024404971	2,528,231 - 2,583,681 (+)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936610	2,528,670 - 2,577,951 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936610	2,528,420 - 2,579,156 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

VGLL3
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	13	168,790,207 - 168,836,927 (+)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	13	168,790,024 - 168,839,962 (+)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	13	179,675,642 - 179,725,107 (+)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

VGLL3
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	22	89,927,526 - 89,972,790 (+)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	22	89,928,227 - 89,973,245 (+)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666041	76,754,073 - 76,804,505 (-)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Vgll3
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624789	3,232,287 - 3,271,600 (-)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624789	3,226,581 - 3,271,940 (-)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in VGLL3
34 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 3p12.2-11.2(chr3:80320584-87468216)x3	copy number gain	See cases [RCV000051499]	Chr3:80320584..87468216 [GRCh38] Chr3:80369734..87517366 [GRCh37] Chr3:80452424..87600056 [NCBI36] Chr3:3p12.2-11.2	uncertain significance
GRCh38/hg38 3p12.2-11.1(chr3:82912987-90179222)x1	copy number loss	See cases [RCV000051542]	Chr3:82912987..90179222 [GRCh38] Chr3:82962138..90228372 [GRCh37] Chr3:83044828..90311062 [NCBI36] Chr3:3p12.2-11.1	pathogenic
GRCh38/hg38 3p12.2-11.1(chr3:83366150-88146360)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053959]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053959]\|See cases [RCV000053959]	Chr3:83366150..88146360 [GRCh38] Chr3:83415301..88195510 [GRCh37] Chr3:83497991..88278200 [NCBI36] Chr3:3p12.2-11.1	uncertain significance
NM_016206.2(VGLL3):c.355G>A (p.Glu119Lys)	single nucleotide variant	Malignant melanoma [RCV000066198]	Chr3:86978574 [GRCh38] Chr3:87027724 [GRCh37] Chr3:87110414 [NCBI36] Chr3:3p12.1	not provided
NM_016206.2(VGLL3):c.287G>A (p.Gly96Glu)	single nucleotide variant	Malignant melanoma [RCV000066199]	Chr3:86978642 [GRCh38] Chr3:87027792 [GRCh37] Chr3:87110482 [NCBI36] Chr3:3p12.1	not provided
NM_016206.2(VGLL3):c.937+6219G>A	single nucleotide variant	Lung cancer [RCV000093787]	Chr3:86962371 [GRCh38] Chr3:87011521 [GRCh37] Chr3:3p12.1	uncertain significance
GRCh38/hg38 3p12.3-11.1(chr3:76764260-89682935)x1	copy number loss	See cases [RCV000135700]	Chr3:76764260..89682935 [GRCh38] Chr3:76813411..89732085 [GRCh37] Chr3:76896101..89814775 [NCBI36] Chr3:3p12.3-11.1	likely pathogenic
GRCh38/hg38 3p12.1-11.2(chr3:86917979-87234450)x1	copy number loss	See cases [RCV000136698]	Chr3:86917979..87234450 [GRCh38] Chr3:86967129..87283600 [GRCh37] Chr3:87049819..87366290 [NCBI36] Chr3:3p12.1-11.2	uncertain significance
GRCh38/hg38 3p14.3-11.1(chr3:57140424-90259960)x1	copy number loss	See cases [RCV000139626]	Chr3:57140424..90259960 [GRCh38] Chr3:57174452..90309110 [GRCh37] Chr3:57149492..90391800 [NCBI36] Chr3:3p14.3-11.1	pathogenic
GRCh38/hg38 3p13-11.1(chr3:73824871-90453699)x1	copy number loss	See cases [RCV000141881]	Chr3:73824871..90453699 [GRCh38] Chr3:73874022..90502849 [GRCh37] Chr3:73956712..90585539 [NCBI36] Chr3:3p13-11.1	pathogenic
GRCh38/hg38 3p12.3-11.1(chr3:74649382-89495681)x1	copy number loss	See cases [RCV000143665]	Chr3:74649382..89495681 [GRCh38] Chr3:74698533..89544831 [GRCh37] Chr3:74781223..89627521 [NCBI36] Chr3:3p12.3-11.1	pathogenic
GRCh37/hg19 3p26.3-q29(chr3:61892-197851986)x3	copy number gain	See cases [RCV000511055]	Chr3:61892..197851986 [GRCh37] Chr3:3p26.3-q29	pathogenic
GRCh37/hg19 3p26.3-q29(chr3:61892-197851986)	copy number gain	See cases [RCV000512358]	Chr3:61892..197851986 [GRCh37] Chr3:3p26.3-q29	pathogenic
GRCh37/hg19 3p26.3-q29(chr3:61495-197838262)x3	copy number gain	not provided [RCV000742138]	Chr3:61495..197838262 [GRCh37] Chr3:3p26.3-q29	pathogenic
GRCh37/hg19 3p26.3-q29(chr3:60174-197948027)x3	copy number gain	not provided [RCV000742133]	Chr3:60174..197948027 [GRCh37] Chr3:3p26.3-q29	pathogenic
NM_016206.4(VGLL3):c.877G>A (p.Ala293Thr)	single nucleotide variant	not specified [RCV004296269]	Chr3:86968650 [GRCh38] Chr3:87017800 [GRCh37] Chr3:3p12.1	uncertain significance
GRCh37/hg19 3p12.1-11.2(chr3:86841600-87862816)x3	copy number gain	not provided [RCV001005452]	Chr3:86841600..87862816 [GRCh37] Chr3:3p12.1-11.2	uncertain significance
GRCh37/hg19 3p13-q12.1(chr3:72488757-99614758)x3	copy number gain	not provided [RCV002221455]	Chr3:72488757..99614758 [GRCh37] Chr3:3p13-q12.1	likely pathogenic
GRCh37/hg19 3p12.1-11.2(chr3:86841601-87862816)x3	copy number gain	not provided [RCV002473443]	Chr3:86841601..87862816 [GRCh37] Chr3:3p12.1-11.2	uncertain significance
NM_016206.4(VGLL3):c.238G>A (p.Glu80Lys)	single nucleotide variant	not specified [RCV004086212]	Chr3:86978691 [GRCh38] Chr3:87027841 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.817C>T (p.Pro273Ser)	single nucleotide variant	not specified [RCV004190570]	Chr3:86968710 [GRCh38] Chr3:87017860 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.593C>T (p.Ala198Val)	single nucleotide variant	not specified [RCV004122778]	Chr3:86968934 [GRCh38] Chr3:87018084 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.622C>A (p.Pro208Thr)	single nucleotide variant	not specified [RCV004096036]	Chr3:86968905 [GRCh38] Chr3:87018055 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.29C>T (p.Pro10Leu)	single nucleotide variant	not specified [RCV004226428]	Chr3:86990715 [GRCh38] Chr3:87039865 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.381G>T (p.Met127Ile)	single nucleotide variant	not specified [RCV004148987]	Chr3:86978548 [GRCh38] Chr3:87027698 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.781C>T (p.Pro261Ser)	single nucleotide variant	not specified [RCV004101371]	Chr3:86968746 [GRCh38] Chr3:87017896 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.470C>A (p.Pro157His)	single nucleotide variant	not specified [RCV004241014]	Chr3:86969057 [GRCh38] Chr3:87018207 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.103C>A (p.Pro35Thr)	single nucleotide variant	not specified [RCV004201867]	Chr3:86990641 [GRCh38] Chr3:87039791 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.715C>T (p.Arg239Cys)	single nucleotide variant	not specified [RCV004081603]	Chr3:86968812 [GRCh38] Chr3:87017962 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.751G>T (p.Ala251Ser)	single nucleotide variant	not specified [RCV004272224]	Chr3:86968776 [GRCh38] Chr3:87017926 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.407G>A (p.Ser136Asn)	single nucleotide variant	not specified [RCV004273745]	Chr3:86969120 [GRCh38] Chr3:87018270 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.53A>G (p.Tyr18Cys)	single nucleotide variant	not specified [RCV004360565]	Chr3:86990691 [GRCh38] Chr3:87039841 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.670G>A (p.Asp224Asn)	single nucleotide variant	not specified [RCV004354916]	Chr3:86968857 [GRCh38] Chr3:87018007 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.225A>G (p.Lys75=)	single nucleotide variant	not provided [RCV003437918]	Chr3:86978704 [GRCh38] Chr3:87027854 [GRCh37] Chr3:3p12.1	likely benign
NM_016206.4(VGLL3):c.105G>A (p.Pro35=)	single nucleotide variant	not provided [RCV003437919]	Chr3:86990639 [GRCh38] Chr3:87039789 [GRCh37] Chr3:3p12.1	likely benign
NM_016206.4(VGLL3):c.102G>C (p.Gln34His)	single nucleotide variant	not specified [RCV004480418]	Chr3:86990642 [GRCh38] Chr3:87039792 [GRCh37] Chr3:3p12.1	likely benign
NM_016206.4(VGLL3):c.227A>C (p.Asp76Ala)	single nucleotide variant	not specified [RCV004480419]	Chr3:86978702 [GRCh38] Chr3:87027852 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.229C>A (p.Gln77Lys)	single nucleotide variant	not specified [RCV004480420]	Chr3:86978700 [GRCh38] Chr3:87027850 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.643G>A (p.Val215Met)	single nucleotide variant	not specified [RCV004482405]	Chr3:86968884 [GRCh38] Chr3:87018034 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.887G>T (p.Gly296Val)	single nucleotide variant	not specified [RCV004482407]	Chr3:86968640 [GRCh38] Chr3:87017790 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.890C>G (p.Ala297Gly)	single nucleotide variant	not specified [RCV004482408]	Chr3:86968637 [GRCh38] Chr3:87017787 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.427C>T (p.Arg143Trp)	single nucleotide variant	not specified [RCV004480421]	Chr3:86969100 [GRCh38] Chr3:87018250 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.757T>A (p.Ser253Thr)	single nucleotide variant	not specified [RCV004482406]	Chr3:86968770 [GRCh38] Chr3:87017920 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.428G>A (p.Arg143Gln)	single nucleotide variant	not specified [RCV004681012]	Chr3:86969099 [GRCh38] Chr3:87018249 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.470C>T (p.Pro157Leu)	single nucleotide variant	not specified [RCV004681013]	Chr3:86969057 [GRCh38] Chr3:87018207 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.364A>T (p.Ile122Phe)	single nucleotide variant	not specified [RCV004681015]	Chr3:86978565 [GRCh38] Chr3:87027715 [GRCh37] Chr3:3p12.1	uncertain significance
GRCh37/hg19 3p12.2-11.1(chr3:80206269-90502849)x3	copy number gain	not provided [RCV004819466]	Chr3:80206269..90502849 [GRCh37] Chr3:3p12.2-11.1	uncertain significance
NM_016206.4(VGLL3):c.911T>A (p.Ile304Lys)	single nucleotide variant	not specified [RCV004881998]	Chr3:86968616 [GRCh38] Chr3:87017766 [GRCh37] Chr3:3p12.1	uncertain significance
NM_016206.4(VGLL3):c.490G>A (p.Gly164Arg)	single nucleotide variant	not specified [RCV004881999]	Chr3:86969037 [GRCh38] Chr3:87018187 [GRCh37] Chr3:3p12.1	uncertain significance

Confirmed Target Of

miRNA Gene	Mature miRNA	Method Name	Result Type	Data Type	Support Type	PMID
MIR24-2	hsa-miR-24-3p	Mirtarbase	external_info	Sequencing	Functional MTI (Weak)	20138800
MIR24-1	hsa-miR-24-3p	Mirtarbase	external_info	Sequencing	Functional MTI (Weak)	20138800

Predicted Target Of

	Summary Value
Count of predictions:	3937
Count of miRNA genes:	1276
Interacting mature miRNAs:	1659
Transcripts:	ENST00000383698, ENST00000398399, ENST00000494229
Prediction methods:	Miranda, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
597272443	GWAS1368517_H	high density lipoprotein cholesterol measurement QTL GWAS1368517 (human)		2e-08	high density lipoprotein cholesterol measurement	blood triglyceride level (CMO:0000118)	3	86988393	86988394	Human
597257098	GWAS1353172_H	triglyceride measurement QTL GWAS1353172 (human)		4e-09	triglyceride measurement	blood triglyceride level (CMO:0000118)	3	86988393	86988394	Human
597147804	GWAS1243878_H	prostate carcinoma QTL GWAS1243878 (human)		7e-08	prostate carcinoma		3	86942448	86942450	Human
597023694	GWAS1119768_H	breast carcinoma QTL GWAS1119768 (human)		1e-09	mammary gland integrity trait (VT:0010552)	blood high density lipoprotein cholesterol level (CMO:0000052)	3	86988393	86988394	Human
597145483	GWAS1241557_H	prostate carcinoma QTL GWAS1241557 (human)		2e-23	prostate carcinoma		3	86942448	86942450	Human
596958200	GWAS1077719_H	high density lipoprotein cholesterol measurement QTL GWAS1077719 (human)		1e-09	high density lipoprotein cholesterol measurement		3	86988393	86988394	Human
597151194	GWAS1247268_H	prostate carcinoma QTL GWAS1247268 (human)		5e-18	prostate carcinoma		3	86942448	86942450	Human
597322295	GWAS1418369_H	triglyceride measurement QTL GWAS1418369 (human)		1e-11	triglyceride measurement	blood triglyceride level (CMO:0000118)	3	86988393	86988394	Human
597273287	GWAS1369361_H	triglyceride measurement QTL GWAS1369361 (human)		5e-09	triglyceride measurement	blood triglyceride level (CMO:0000118)	3	86988393	86988394	Human
597035465	GWAS1131539_H	triglyceride measurement QTL GWAS1131539 (human)		1e-10	triglyceride measurement	blood triglyceride level (CMO:0000118)	3	86988393	86988394	Human
597036057	GWAS1132131_H	high density lipoprotein cholesterol measurement QTL GWAS1132131 (human)		3e-11	high density lipoprotein cholesterol measurement	blood high density lipoprotein cholesterol level (CMO:0000052)	3	86988393	86988394	Human
597267126	GWAS1363200_H	triglyceride measurement QTL GWAS1363200 (human)		6e-09	triglyceride measurement	blood triglyceride level (CMO:0000118)	3	86988393	86988394	Human

A004P25

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	86,987,252 - 86,987,352	UniSTS	GRCh37
Build 36	3	87,069,942 - 87,070,042	RGD	NCBI36
Celera	3	87,739,176 - 87,739,276	RGD
Cytogenetic Map	3	p12.1	UniSTS
HuRef	3	87,000,567 - 87,000,667	UniSTS
GeneMap99-GB4 RH Map	3	262.81	UniSTS
NCBI RH Map	3	683.7	UniSTS

SHGC-68425

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	86,990,443 - 86,990,532	UniSTS	GRCh37
Build 36	3	87,073,133 - 87,073,222	RGD	NCBI36
Celera	3	87,742,367 - 87,742,456	RGD
Cytogenetic Map	3	p12.1	UniSTS
HuRef	3	87,003,758 - 87,003,847	UniSTS
TNG Radiation Hybrid Map	3	52661.0	UniSTS

RH102693

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	86,996,060 - 86,996,188	UniSTS	GRCh37
Build 36	3	87,078,750 - 87,078,878	RGD	NCBI36
Celera	3	87,747,986 - 87,748,114	RGD
Cytogenetic Map	3	p12.1	UniSTS
HuRef	3	87,009,375 - 87,009,503	UniSTS
GeneMap99-GB4 RH Map	3	261.42	UniSTS

G20437

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	86,989,852 - 86,990,035	UniSTS	GRCh37
Build 36	3	87,072,542 - 87,072,725	RGD	NCBI36
Celera	3	87,741,776 - 87,741,959	RGD
Cytogenetic Map	3	p12.1	UniSTS
HuRef	3	87,003,167 - 87,003,350	UniSTS

A005R17

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	86,989,852 - 86,990,035	UniSTS	GRCh37
Build 36	3	87,072,542 - 87,072,725	RGD	NCBI36
Celera	3	87,741,776 - 87,741,959	RGD
Cytogenetic Map	3	p12.1	UniSTS
HuRef	3	87,003,167 - 87,003,350	UniSTS
GeneMap99-GB4 RH Map	3	264.48	UniSTS
NCBI RH Map	3	683.7	UniSTS

SHGC-77133

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	86,991,571 - 86,991,848	UniSTS	GRCh37
Build 36	3	87,074,261 - 87,074,538	RGD	NCBI36
Celera	3	87,743,495 - 87,743,773	RGD
Cytogenetic Map	3	p12.1	UniSTS
HuRef	3	87,004,886 - 87,005,164	UniSTS
TNG Radiation Hybrid Map	3	52616.0	UniSTS
GeneMap99-GB4 RH Map	3	264.48	UniSTS
NCBI RH Map	3	683.7	UniSTS

D15S1269

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	86,987,157 - 86,987,298	UniSTS	GRCh37
Build 36	3	87,069,847 - 87,069,988	RGD	NCBI36
Celera	3	87,739,081 - 87,739,222	RGD
Cytogenetic Map	3	p12.1	UniSTS
HuRef	3	87,000,472 - 87,000,613	UniSTS

SHGC-77128

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	87,037,603 - 87,037,773	UniSTS	GRCh37
Build 36	3	87,120,293 - 87,120,463	RGD	NCBI36
Celera	3	87,789,520 - 87,789,690	RGD
Cytogenetic Map	3	p12.1	UniSTS
HuRef	3	87,050,913 - 87,051,083	UniSTS
TNG Radiation Hybrid Map	3	52590.0	UniSTS
GeneMap99-GB4 RH Map	3	261.8	UniSTS
NCBI RH Map	3	679.4	UniSTS

G20685

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	86,990,487 - 86,990,592	UniSTS	GRCh37
Build 36	3	87,073,177 - 87,073,282	RGD	NCBI36
Celera	3	87,742,411 - 87,742,516	RGD
Cytogenetic Map	3	p12.1	UniSTS
HuRef	3	87,003,802 - 87,003,907	UniSTS

A006B39

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	86,990,487 - 86,990,592	UniSTS	GRCh37
Build 36	3	87,073,177 - 87,073,282	RGD	NCBI36
Celera	3	87,742,411 - 87,742,516	RGD
Cytogenetic Map	3	p12.1	UniSTS
HuRef	3	87,003,802 - 87,003,907	UniSTS
GeneMap99-GB4 RH Map	3	264.48	UniSTS
NCBI RH Map	3	683.7	UniSTS

RH45063

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	86,992,713 - 86,992,836	UniSTS	GRCh37
Build 36	3	87,075,403 - 87,075,526	RGD	NCBI36
Celera	3	87,744,638 - 87,744,761	RGD
Cytogenetic Map	3	p12.1	UniSTS
HuRef	3	87,006,027 - 87,006,150	UniSTS
GeneMap99-GB4 RH Map	3	262.81	UniSTS
NCBI RH Map	3	683.7	UniSTS

RH69879

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	86,990,642 - 86,990,762	UniSTS	GRCh37
Build 36	3	87,073,332 - 87,073,452	RGD	NCBI36
Celera	3	87,742,566 - 87,742,686	RGD
Cytogenetic Map	3	p12.1	UniSTS
HuRef	3	87,003,957 - 87,004,077	UniSTS
GeneMap99-GB4 RH Map	3	264.48	UniSTS
NCBI RH Map	3	683.7	UniSTS

UniSTS:487342

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	3	86,987,204 - 86,988,568	UniSTS	GRCh37
Celera	3	87,739,128 - 87,740,492	UniSTS
HuRef	3	87,000,519 - 87,001,883	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	pharyngeal arch	renal system	reproductive system	respiratory system	sensory system	visual system
1204	2379	2788	2232	4925	1699	2274	6	602	1263	444	2249	6531	5801	45	3698	1	801	1719	1563	174	1


RefSeq Transcripts	NM_001320493	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001320494	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_016206	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_006713138	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054346475	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AA455617	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC108709	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AF099505	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AI379920	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK095826	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC017383	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC062478	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC094780	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BX369995	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BX391744	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CF995043	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471110	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CN287582	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068275	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CR936700	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DA828655	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DB319377	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	HH756203	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	HH756215	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	HH792471	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	HH792483	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000383698 ⟹ ENSP00000373199

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	86,961,906 - 86,991,119 (-)	Ensembl

Ensembl Acc Id:

ENST00000398399 ⟹ ENSP00000381436

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	86,937,973 - 86,991,149 (-)	Ensembl

Ensembl Acc Id:

ENST00000494229 ⟹ ENSP00000419115

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	86,968,703 - 86,990,702 (-)	Ensembl

Ensembl Acc Id:

ENST00000637106 ⟹ ENSP00000489678

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	3	86,876,388 - 86,968,631 (-)	Ensembl

RefSeq Acc Id:

NM_001320493 ⟹ NP_001307422

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	86,961,906 - 86,991,149 (-)	NCBI
CHM1_1	3	86,963,667 - 86,992,830 (-)	NCBI
T2T-CHM13v2.0	3	87,036,241 - 87,065,510 (-)	NCBI

Sequence:

show sequence

GTATATGCAAACCGGAGCTGGGCTCCCCACGGCTGCCCGACCCGGGCCTGGGCTGTGGCTGTGACTGGCGCTGCCGTGGGCGCCGCAGCCCTCGCGGGAGCCGGACGCGGTAATGCCCCAGCGGCGCA
GCGGGCGGCTGCGTCCCTGAGCCGCTATATAAGCGCGGCAGGGAACATCCGGAGGGGCTGAAGATGAAGGTGCCCGCGCATGGGCCCCCGCTGATTGCCAGTCCCTCCCGACCCCGCGCCCCGCGCGG
AGCCCGAGGCCGCCGAGGACCCGCCTTCGCCGCAGTAGCAGCTGGAGCAGCGACAGAGGCGGCAGCTGCGGCGGCGGCGGCGCCCGCGCCCCTCGCGCCAGCGCGTAGAGCGGCGGCGGCAGCTCGGG
GGCCGCCACTGCCCCGGCTGCCATGAGTTGTGCGGAGGTGATGTATCACCCCCAGCCTTATGGAGCGTCCCAGTATCTGCCCAACCCCATGGCAGCGACAACCTGCCCCACAGCCTACTATCAGCCGG
CGCCCCAACCTGGCCAGCAGAAGAAGTTAGCGGTATTCAGCAAGATGCAGGACTCTCTGGAAGTCACCCTTCCCAGCAAACAAGAGGAGGAGGATGAGGAGGAGGAGGAGGAGGAGAAAGACCAGCCT
GCCGAGATGGAGTACCTTAACTCTCGCTGTGTCCTTTTCACTTATTTCCAGGGAGACATTGGGTCAGTAGTGGATGAACACTTCTCAAGAGCTTTGGGCCAAGCCATCACCCTCCATCCAGAATCTGC
CATTTCAAAAAGCAAGATGGGGCTAACCCCCCTATGGCGAGACAGCTCAGCTCTCTCAAGCCAGCGGAATAGTTTCCCAACTTCCTTTTGGACCAGCTCTTACCAGCCCCCACCTGCACCTTGTTTGG
GGGGAGTTCATCCTGACTTCCAGGTCACTGGACCCCCTGGCACCTTTTCTGCAGCTGATCCCAGTCCTTGGCCGGGACACAACCTGCATCAGACTGGCCCAGCCCCTCCCCCTGCTGTGTCTGAGTCC
TGGCCTTATCCTTTGACATCTCAGGTGAGCCCATCCTACAGCCATATGCATGACGTGTACATGCGGCACCACCACCCTCATGCCCACATGCACCACCGCCACCGCCACCATCATCACCATCACCACCC
TCCTGCTGGCTCTGCCCTGGATCCATCCTATGGGCCTCTGCTGATGCCTTCAGTGCATGCGGCCAGGATTCCTGCTCCCCAGTGTGACATCACAAAGACAGAACCAACTACAGTCACCTCTGCTACCT
CAGCATGGGCTGGAGCCTTTCATGGAACAGTAGACATAGTGCCCAGCGTGGGATTCGATACAGGCTGGAGTGCAATGGCGAGATCTTGACTCACTGCAACCTCTGCCTCCCGAGTTCAACCAATTGTC
CTGCCTCAGCCACCTGAGTAGCTGGAATTACAGGCATCTGCCACCACGCCCGGCTAATTTTTTGTATTTTTAGTAGATAGTCACTATTTTGAATAGTGAAGGCTGGCTTCCCTATTTTGAATAGTGAA
GGCTGGCTTCCCTATTTTGAATAGTGAAGGCTGGCTTCCCTATTTTGGCCAGGCTGGTCTCAAACTCCTGACCTCGTGATCCACCTGCCTCGGACTCCCAAGGTGCTGGGATTACAGGTGTGAGCCAC
TGTGTCCAGCCCTCATGTACAAATTTTTAAGTAAATGTGTGTTTAATTCTCTTGGAAATATATCTAGGAGTAGAACTGTGGGGTTAAGAGAACCTCACTTTTTATTTTATGTATTTCTATATTTTTTG
AATTTTTTTCAAAGAGCATATATATGCAATTTTTAAAATATTTAAATTTAAATTTTTGTTTTTTAAATTTTTTTTTAGTATTTAAATTGTTAAGATTCATTACAACATATTATAGTAGAGTTTGAGGT
TTGGTAGGCAAAACTGCCATAGGAATGAAGTAAGGTGGTCCATTTTTTCCGAAGGGCTGAGTGGTGGTGAGGACAGTGAGGTGCCTCTGGCACAAAATTTAAAAGGATCCATACTGTGAGGGCTGTGC
AAGTGTATGCCACCCCATATTTTGCACCCAGGGCTCCTTATTCCTCTAACCTCTGTCTTGGTGTTGCTTTGCTGTCATGCGAGCTCACTCTTACTTTTTGCTCCCTCTGTTGAACAGGTATTACATAC
AGGTACCTTGAAATGATCAGTATGGTATGATCATAAGTCATTTGTATTTGCCCTCCACGTGAAAAATGCTCATCTTTACCAAGAGGCTGTTATCACAAATCTCACATTAGGCTTTTTCCCTTTCCTTT
ATCAGTCTTTAAACTGAGTTTCATGGGTTCCATAGGAAAAATACTCAGAATGTGATAATAAGGGCTTAATTGAAAAAAGAAAAGATCTATTATCAAATGAATTTATTTACATTGCCTACCATATACCT
CTTAGAGATCACAGTTCCCTATAGCATATAAAATGTTTTATATATTCTTCAGTAAAAAAGCATTTTAAATTGT

hide sequence

RefSeq Acc Id:

NM_001320494 ⟹ NP_001307423

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	86,937,973 - 86,991,149 (-)	NCBI
CHM1_1	3	86,939,745 - 86,992,830 (-)	NCBI
T2T-CHM13v2.0	3	87,012,305 - 87,065,510 (-)	NCBI

Sequence:

show sequence

GTATATGCAAACCGGAGCTGGGCTCCCCACGGCTGCCCGACCCGGGCCTGGGCTGTGGCTGTGACTGGCGCTGCCGTGGGCGCCGCAGCCCTCGCGGGAGCCGGACGCGGTAATGCCCCAGCGGCGCA
GCGGGCGGCTGCGTCCCTGAGCCGCTATATAAGCGCGGCAGGGAACATCCGGAGGGGCTGAAGATGAAGGTGCCCGCGCATGGGCCCCCGCTGATTGCCAGTCCCTCCCGACCCCGCGCCCCGCGCGG
AGCCCGAGGCCGCCGAGGACCCGCCTTCGCCGCAGTAGCAGCTGGAGCAGCGACAGAGGCGGCAGCTGCGGCGGCGGCGGCGCCCGCGCCCCTCGCGCCAGCGCGTAGAGCGGCGGCGGCAGCTCGGG
GGCCGCCACTGCCCCGGCTGCCATGAGTTGTGCGGAGGTGATGTATCACCCCCAGCCTTATGGAGCGTCCCAGTATCTGCCCAACCCCATGGCAGCGACAACCTGCCCCACAGCCTACTATCAGCCGG
CGCCCCAACCTGGCCAGCAGGGAGACATTGGGTCAGTAGTGGATGAACACTTCTCAAGAGCTTTGGGCCAAGCCATCACCCTCCATCCAGAATCTGCCATTTCAAAAAGCAAGATGGGGCTAACCCCC
CTATGGCGAGACAGCTCAGCTCTCTCAAGCCAGCGGAATAGTTTCCCAACTTCCTTTTGGACCAGCTCTTACCAGCCCCCACCTGCACCTTGTTTGGGGGGAGTTCATCCTGACTTCCAGGTCACTGG
ACCCCCTGGCACCTTTTCTGCAGCTGATCCCAGTCCTTGGCCGGGACACAACCTGCATCAGACTGGCCCAGCCCCTCCCCCTGCTGTGTCTGAGTCCTGGCCTTATCCTTTGACATCTCAGGTGAGCC
CATCCTACAGCCATATGCATGACGTGTACATGCGGCACCACCACCCTCATGCCCACATGCACCACCGCCACCGCCACCATCATCACCATCACCACCCTCCTGCTGGCTCTGCCCTGGATCCATCCTAT
GGGCCTCTGCTGATGCCTTCAGTGCATGCGGCCAGGATTCCTGCTCCCCAGTGTGACATCACAAAGACAGAACCAACTACAGTCACCTCTGCTACCTCAGCATGGGCTGGAGCCTTTCATGGAACAGT
AGACATAGTGCCCAGCGTGGGATTCGATACAGGTCTACAGCATCAAGACAAGAGTAAGGAATCACCGTGGTACTGAAACACACAATCTTAGTGAGTTAAGTTGCAGCATAAATCCAAGGGCCCACTGG
GAAAAGATACTGTCGGGTTTTTCCATTCAGCAATAGGACACGAAAGGCATAGAAGGAGAAGACAAAGTGTCACGCAGTTGACTGGTTTTCGGCCTTTCTTGAGAAAGCAAAGTGGGTCCCAGACATTG
AAGAAAAGCATTTTTATTTGTTTATTTCCTCATCTGAGCCTTTGCCAACTGTGCAACTCTCTCCTTTTGTTATCTTGCTTTTATCAATATATAGCTAAGTTTTTGTTTCATTTTGATTTTTTTTTTTA
GCCAACCACCTTGTCAGGAAAGGATGAACCACACATTAAAATGTTCATTCTTTCAGGAATACAAGTTTGTAGCTCTATGTGCATCTATTTTTGTAGAAATACAAAAAGTTTGGTTTAGCATTGATGGG
CTATTTTTGAGGGATGTATTTTTTTTAAAATTGTAAAAATTGTTGAGTTCTGTTTAAAGAACTTGCTCTCAGAGAAGCACTGGCAAAAATGTTTAAAATGCTTATCTCTAAGATGTCTATTATATGCT
CTGTCTGTGCTTTCTAGGTTACCTCAAATGTTTTGTTTTTTTCCTTCTTACAAAAGTAGCTATACCGTAGTCAAACCAATGCAGTATTGTTTTTACATTGAATCTCAGTAAAGATTTAATTCCATGCT
AGCTCAATTAGTTTTGAATTATATGTATAGCTTGAAAAGTTTTTTTTTAATGACTGTGCTAAAGAAATGATATTTTATTGCTTTGATTTCTCCCAAAGAATAACTTGGAGGTTGACTAATAAGAAAGT
TGGCATAAACTTTCAATCAAATGAAGAGTTTGCCTAGAGGAGACTAATTCTCTTTCTAGCCCATCCAAATTTGATAAATGGAACCAGAGGTTATATACAACTACAAGGAAAAAAATGCATTTAACCAT
GCCACCTATGAGTGCCAGTGACTTATTTTACTTGTTTTTAATTATTCATTCATGGCAATTTAAAAAGTCATATTTTAAGTGGGATTTGTTTTTCCTGAAGGGCATTTGAAGGAACAATATCTGGGAAG
GTACTAGAGAAATTACAAAGCCCGAGCTCTTTCTTATAATGCCACCTATCCCTGTAAGCTAAACAAACAAACAAACAAACAAACAAACAGTTCTATATATAATAGTTTCAACACAGAACTTAACAAGT
CTCTTTTTTTGTTTGTTTAAATCTGGCTTTACTTGATTTAATTCCTTTTTAGAAAGAAATTTAGGGCAAAATAAAGTGTATATTAGGATTTAAATTTATGCCACAATTTAAAAATAAAACCAGAGGTT
ATATACAATTTAAATTGGGCTAAAAATTAAAAATTTGAGGATTTAACTTGATATAGCTCTCAGGATCTAAATAAAGTTTAAATTATCATTAAGACACTGCTAGGAGAAGATTAAGATTATGAAAGTAA
CAGTTATTGATACTGCTGGACTTCAAAGGCAAAGTTCATTTCTTCCATTAACTGCTTCCAGAGATGTCATGTAAAAAAGTTAGTGTATTAGAGAAGTTTTTTAGCTTTATAAAGAGGTTTTTTCAAAT
TTCTCCCATTTTTCTCTCCACCCACATAAAATAGTATGTTCAGTGAAATGCCACTTTCTATCTTTAATTGTTCGTATCATATATGCGAACTTTTTAGACATGAACATGACATGTTCAGCTAGGCAGAG
TTCTCATAGATAATTTTCAAATATTTTCCTTGGCTGTAATTTATGTATTCATTTATATCCTATCCGTCTTTTGAGCTTCAGATCTATATACTCTTTTGTACTCTCATCACTCCGCACTTTGCTGTTTC
TTACCTAGACTCTCTTTTACACAATATGCACATTTTTACCATTGTGGGGTCCAAATTTAAGATACCTTCCACTCACTAATAATATGAACTTATATTTCCTGGGAGTAGCCAGGTTAAATTTTCTATAC
TTTGGTCCATAATTTGATTTGATATGATTGTTTCATTTATAATTTGCCCAAATACATGGAGCACAAAATTTAGTGAATTTATAAATCTGGATTTGCCTTGTGTCCTTCTGAGTTTTCAAAGGCAAGTA
TTCAACAGTCCCTGTGTGATGACTGACAGGGTTATTTGCCTCATCCACATCCACCTTCGGAATACATTAACTTCCTTTGTAATTTATTTGAAAGTAGTGTTAAACTCATTCAGATCATTCAGTTGGAT
TTTCCCAATGAAGAGGAAAAGGAAAGTAGTTATTCCTAGCTCCATTTCTTATTTTCCACCAAATTTAATTGAAGGGCATTAATTAGATGTCTTCACCCTGAATTTAGACTTTGCTCTGTGTTCTCCCG
GTAACTGTCAGACAAAAAGTTTATTGGCTCTGAGGAACTGAGAAATGTTGGGAACCTGGTTTCTGCTGTACACAGGAAAGATTTGTAAGTGAGCTCTCTCTTTGAAAACAGGACCCAGGCTGGGCACA
GCAGCTCATGCCTGTAATCCTAGTATTATAGGAGGCAGAGGCTCGGGAGGATTGCTTGAGCCCAGGAGTTCAAGATCAGCCTAGGCAACATAGGGAGACCCTATCCCTACAAAAAATTTCTGAAAAAT
TACCTGGGCATTGTGGGGCACACCTGTTGTCCCAGCTACTCTGGAGGCTGAGTCCGGAGGAACGTTTGAGCCTGGGAGTTTGAGTTTGCAGCTTGCAGTGAGCTGTGATTGCACCACTGTACTCCAGC
TTGGGCAACAGAGCAAGATCCTGTCTCAAAAGGAAAAAGAAAACAGGACCTAGGTGTTTGGGGTACACTGCCACCCAGGGAGTGGATCAAAAATATACATAGAAAGAGAATGAGCATGTCTCTATAAT
TGTCTTCTAGGACCATATTGCTGTTAGAAGTCCTAAAAGAGGATGGGTTGTAATTTAGCATAATATTCTGAATTCATTCCAAGTTTAAAATCCTGTCATTCTCTGGCTCTTCTTTTTTCACATCAAAA
TGATGCTGTTGGACTTAGAGGCTTCCGAACTGTTTTATTGAGGGCTACTATCTGCCTCCACAATTTTATTAAAACCACTCCACCTTTAGACAAAGGTGACTTTTGTCTGATTTTACAAATCAGATTTT
ATTCAAGCTTTCTAAATATCTGTGAAGTAGACCCTAGAAAATTGTCTCGTTTATTTTAAATAGAATCTATGCTTCCACCAATAAACCATCGGGAGCTAAGAAACAACATAATGTTGACAAATCAGGAA
CCTAACAGATTATTTTGTCTCTCATTATTAATTTGAAAGAGCCTCTAAACTTTTGAGAAATCAATGTGTCTTCTTAAGAAAGTTAAGCACCCTCTCTTAACTTTCCCCTCTATTTGCTCTCCTTTTTC
TTTCTTCTTAAGAGTATTTATATTATTTTGTTAAGCAAAAATGGCTAAGATTGCTCTAAAATTTGCAAAATGAGGAGTGGATTGCAAATAATTGAGGGATTTATTTCTTTAACTTTATAAGACTTTAA
AAAAAAAACCCAAATTCTAAGCACTGACATGAAAGTTGCCTTTGAGAAGCTTGTTATTCATTATACAAAAAGTATTTGCCCATTCCTATTCTAAGATTTGCAGAATATGTCACCCTATCTAGCTTTTG
AGTTTGCTATCTGGTTTAATGTTGTATTTATAATTTAAAGTGGAAATCAGAAACTGTTTCAAGAACCTGTATTCTATTCCTTACTGAGTGTCCCTTCTTTAAATAGTGTTTGCTGAATTAAGCCGATG
GGGGCAGTGGCGTTAAGTGGTGGAAAAAGGAAAGTATATATGTTAGAGTTTTGAATGAGGGATAAATAGAAAGCAGAATGAATTAATGGAAAAGAACTCGGCTGTTAGGCCATTCTCTAAATTCTAGT
TTAGCCAAAAGTTTATGTGTGGTTTGGGGCTTCATTTATTTATCTCATGAGTAAAATGGAATAATACCTAACAGGCAGGCTCTGGAAGTTGGAAATCACATACACACACACACACACACAGACACACA
CACACACGATCAATCATGTAGCTCATATTAGATGTTCAATAAATAACAGCTACTACAGATGCCTATCAGTTGAGTAAGTAGTTCATTAAATTGAGCTCCCAAAGGTCTCTTCTCTTCACATCCATATC
CGTTTCTGCAGCAATCAAATAGATACATGATTGTTTTTCTGTAAGAAATTACTGCAAAGAGAATCTTTTTCTCCTACTAACTGTTCCTTCTACCTGGTATAGGAGATAAATGTACGTTTCTTAATTAG
CTGACTTTTTAGTATGTCATTTCTGAAGGAAAAATAAATTAACCTTAAAGTGGCATGTAGGTCCAATTCAGTTTTCCTACATGTTCCAAAATTTTATTTAAATTACTGTGTCCAAAATTATGAGGACA
GTGTCATTCATTCACCATAGTTTATATTTTTAGTTATATATCAAACTTCCTTGGCACCTAGGATAAGAACATTTCTTTTGAAGTTATCCAATTTTTTTTTATTTTTACTTGACTTGAAGGAAAGTTGG
AAAATATGGTGGAAAAAATCTTCCGCATTAAAAGGGGGAAAAACACAACCATTTACGATCTCAGTCAGCAGATTTACTCTACTCAAGGAAAAAAAGAAACAATCTTATTGGAAGCAGATGTTGACACT
GTGTCAGTTATTGAAGACGGAAGGAGTTCACTTGAGCCATTGCAGTTACAAAGGGGTATTGATGGCAGTTTGGATTCCTGATTGATCACCTTTGCAGCCAAGGGAAAGACAGCAGAAACTGTATGGGA
TCAGAAATGAAATCAGCCTGCCAGTTTAATGGAGAGGCTCCTAGAAACTCATTTTTTTTCTTTCCTGTAAGATAAAAGACATCTTTCAGAATAAGAAAGGCTTGTTTGAGAGAGAAATTACAGTTTAT
TCTCTGAAAATATTTAAAGGCCAAAGTGCCCTTTAAATCTATTATTAAAGCATTGAAACTGTTATTAAAATCATTATAGAAAAATTAGGTAAAAATTTTAGCCTAACTTTCAACATCCATTCAAAAAC
GAATGTTGAAAACAAACATATAACCTATAAAAAAGTGAATGGCTCTGGCAAGTGGGGGCATGGGTGGAGTCCATAAGGAAACCTCAGTCTCAATAACTTCAAAATGTTACTTTTCATGGTAACTTGGT
CATGGAGATTGGTCACAGCACAGACATTTAGAATTTTTTAGCAGGTTTTTTTTTTCTTTTGAATCTTGTAGTGCTCTCTGGGAATTGCACCATGTACACTTTTACAACCTACAGAAATCGTCATTATT
GTTAAAGTATCTCAACTTTTCTATTTCTTTTATTGTCTATTGTGCTTTTTTGTTTAAAAATACTTTTATAGTTTTAAAGTATTGGTCAAAGTAGTATTCTCTTGAAGTTCTAGTCAATTTAATTTGAT
CCAATAAGTTTTTCTGAATCTCCTTTTTAAGTTCCAAGAAATTCTATTATAAATAAGTGTACTTTTACCAATTCCATTGTATAAGCAAACAGACACCTTTTAGAAAAGGATAAGTAATCATCAATTTG
TTTTTTTAAAAAAAAAAACAATTTCTAGACTACTAAATTTGGCATAAGAATAATTCTTTTAAAATGCAACATACTTTAATTAGTTTTTTTGGTATATGCATAAGATGTGAACTTTCCTATTGATATCA
CTTTATATTAATAGAGATGTACATTTCTTTCTATGCCGTGGCTAGAGCAAAAGTTAATAATGATTATTTACACAATTGATTTAATTTCTTAGGATATGTATAATATTGGATATTATATCTGATTTAAA
AATACTATTCCATACATTTTTTTTTTCAGGAGATAAAACATAGGGAAAGGTTTTCATGTGAATTCTTTGTATCACTTTGAAGTACATATATTTAAAGGGAAGATGGATACAATTTGTTTTTATTATAT
AAATCTAGGTAAGGTGAAATGCTTTTGTCAACAAAAATACAGTGTAGTGAATTTTATATTTGTCACTTGATTAGGTAAACTGAAAACTAACAATAGAAATATTATTTTACTGCATTGAAATACCATGA
ACTTTCAGACTTGTTAGTTCTACAAGAAGTTGTGCTACCTTAATTTTGTGTTTCCAGAAATAAAAATTAACCTTAGTTATGCTGTCATTTTTAACTAATAAAAAAAGTATAATTCATAAAACTTTTGG
CTTTATAAGATAATTATAAAATTATATATTTTTTTCTGTTTTTGTGGGGTTGGGAAAACATTTTCTTATTTCTATTCACTCTTCAAATGCAGGTCTCATAATATGTGTCAATGATATAAGATGATGGA
AGACTTTGTAATAAAAACATATGTCATTATCTTCAATTTGTTCAATAAATAATTTAATGTGAATTGAATGTTTGTATTTTAACATAGCATTTGGATTTGGTCTGCATTTCTTGAGAATTTAAAGCTCT
TTTTGTTTCCTCCTTATTCAATTAAGCATCTTATAAATATTTTGGAAATTACAACATCTTAGGTGTTATTAATTAAGAAGTTAATTTCTAGGGCCAAGAAGTCTATATGTTACAGCAAGGAATAGATT
ATAAAATACATGTTTATAATGGAAAAGAAAATGAAATGGGGTATATTAATTACATAACAGCAAGAGTCTTGAGAATTTTATAATACAATGCTTCTAAGGATATTGGTTGACCAAGGTGTATTTTATTG
TTTTTACATTTGTTGACAGGGACTCTGCCATAAGTAGTATGAAAAAACAAACAAAAACTTTTCTACGATTCATTAACATTGAAAAGAGAATTCCAAGACCTTGTATTCTGAAGAAAGCTAGAGTTTCT
CTAAGTGGGCCTTCAATTTTCTTATTACACGTATCTTTAATGTGAAAGTACTAAAGTCTGAAAATCAGCATTTAAATAATAGACTTTCCAGCATTACAGATGAAATAATTTGGCGCAGGCTTTTTAAC
TGTCTACCATATTTAGAATGTGGTGTCAAAATGAGATTTTTAGAACTGCTGTAAAATATTACTACATTACTACAACGATAACGGCCTAAAACAACACAAATTTATTATCTTACAGCTCTGTCAGTCAG
ACATTCAGCAAAGATCTTAGTCTTGGTGGGCTACAGAATGTAGGAGGCATTTCCTGGATGCTTCCAAGAGAGAATCTTGCTGTTCCCTGCTTCTAGAGTCCTTTGCTTAGTTTCCTTCCATCTTCAAA
TCCAGCAACCTGGTCAAGACCTTCTCACATGACATCACTGACTTCCTCTTCTTCCTCTCCCTTACATATTTAAGGACTCATGTGATTACAATAGCTGCATCTGTGTAATCCAGAATAATCTCTTCATC
TCAAGGTTTTTGTTCTGTTTTGTTTTTTTGTTTTGTTTTGTTTTGTTTTGTTTTGATGGAGTCTTGCTCTGTCGTCAGGCTGGAGTGCAGTGGCGCGATCTCGGCTCACTCCAACCTCCACCTCCCGG
GTTCAAAGGATTCCCCTGCCTCAGCCTCTCGAGTAGCTGGGACTACAGATGCGTGCTACCACACAAGGCTAATATTTTGTATTTTAGTAGAGACGGGATTTCACCATGTTGGCCAGGATGGTCTCCGT
CTCCTGACCTCGTGATCTGCCTGCCTTGGCCTCCCAAAGTGTTGGGATTACAGGCATAAGCCATTGCGCCATGCTCAAGGTTCTTAATTACATCTTTAAAGGCCCTTTTTCCATGTACAGTAACATAT
TCAATGGTTCTGGGGATTAGGACTTGGAGCCATTATTCTACCTACAACAATTAGTATTGGACTTCCATCATTTTCTATCACTCTTGTAATCGAGAAGGACTATTTCACTGGGAGTAGCAAGTCATAAT
GTTTGCGTTGGCATTTGTGTGGGGGTTTATCTTCATTCATTAAATAATTGCATGTAAAGAAAATTCCTGTCACTATTTCAAATGTTTCATGTAGTTATTATAGTGCTTCAGAATCCAAAGGGTTATGT
GTTACTTATGTAAGATGAGCAGTCTAGGGGGTGGAGAACAGGTCATCTAGTGCAGATTCTTCCTAGCTGAAGTGTGTTTTCTCTGGGGACAACCAAGTAGGATTTAATTGTTTTGCTTCCTTTTTTGG
GAACTTAGACCCATCTTGCGATGTCCTAAGTCTCCAAGCATCTTATTTGACCTGCTTATACACATTTGACTAAATAGCTAAATATGACCACATTGACGTGGTAAAGCTTTAACACTTTTGTCCAGATT
GAATCACTCCATCTGCTATCAGTTAAGCAGTGGAAAACTGTTATGGAAAAGCAAACATGTTTTGATAGATTTAATGTGTAAAGAAGGTATCCATACTCTGGAATGCTGCTGATCAATAAATGAGCTGC
AAGACTTTGTTCGAAACAACACTCAAGCACAACTGTTTTACTTTCCATACCAAGTTTGGCTGTGACTGAATGAAGAACATCAGCATTGATCTTTGCTTTGCACTTGTACAAGAGACTATTTGCAGAGA
GCCAAATATAGCAACAGAGGATTTAATATCTTGCCAAAAAATACAAAATCTGTTCCCCTTTAAGCATGACACTCTATCCTTTCTTGTGGATCTTGCTAAAAGGAAAATATAGCTTTAAACTCCCCTAT
TCCTTCTGTTGAAAGCTTAAGAATCTTTTTCAAATGAGCTATGTATGGTTTTGTGGTATTTTATGTTTCCAAAAGAAAATGGCTACATGAAAAATCTGTCCAGTGTTATCATTTTTCTTACAAAAAAT
ACTTCTAGTTATGGTTGTATTAATTAATTTGATTGTGATAATGATTACACAATGTTTACCTATATCAAATCATCATATCGTATACCTTAAATATATATAACTTTTATGTGTCAATTATAACTCAGTAA
GTCTGGGAAAATATCGTTAAGTCAAAGATTAGAGTCAACAGAAATAAAGAAAAATCATACTTTGATAACTTCAGGACTAATCAAGGATCAATGGGTGACATGATATCATGCTATGTGCCATTTTGTGT
TAAACAAATTACACCAACAATAAAAAAAATTGGCTTCAA

hide sequence

RefSeq Acc Id:

NM_016206 ⟹ NP_057290

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	86,937,973 - 86,991,149 (-)	NCBI
GRCh37	3	86,987,123 - 87,040,412 (-)	NCBI
Build 36	3	87,069,813 - 87,122,947 (-)	NCBI Archive
Celera	3	87,739,047 - 87,793,404 (-)	RGD
HuRef	3	87,000,438 - 87,053,543 (-)	RGD
CHM1_1	3	86,939,745 - 86,992,830 (-)	NCBI
T2T-CHM13v2.0	3	87,012,305 - 87,065,510 (-)	NCBI

Sequence:

show sequence

GTATATGCAAACCGGAGCTGGGCTCCCCACGGCTGCCCGACCCGGGCCTGGGCTGTGGCTGTGA
CTGGCGCTGCCGTGGGCGCCGCAGCCCTCGCGGGAGCCGGACGCGGTAATGCCCCAGCGGCGCAGCGGGCGGCTGCGTCCCTGAGCCGCTATATAAGCGCGGCAGGGAACATCCGGAGGGGCTGAAGA
TGAAGGTGCCCGCGCATGGGCCCCCGCTGATTGCCAGTCCCTCCCGACCCCGCGCCCCGCGCGGAGCCCGAGGCCGCCGAGGACCCGCCTTCGCCGCAGTAGCAGCTGGAGCAGCGACAGAGGCGGCA
GCTGCGGCGGCGGCGGCGCCCGCGCCCCTCGCGCCAGCGCGTAGAGCGGCGGCGGCAGCTCGGGGGCCGCCACTGCCCCGGCTGCCATGAGTTGTGCGGAGGTGATGTATCACCCCCAGCCTTATGGA
GCGTCCCAGTATCTGCCCAACCCCATGGCAGCGACAACCTGCCCCACAGCCTACTATCAGCCGGCGCCCCAACCTGGCCAGCAGAAGAAGTTAGCGGTATTCAGCAAGATGCAGGACTCTCTGGAAGT
CACCCTTCCCAGCAAACAAGAGGAGGAGGATGAGGAGGAGGAGGAGGAGGAGAAAGACCAGCCTGCCGAGATGGAGTACCTTAACTCTCGCTGTGTCCTTTTCACTTATTTCCAGGGAGACATTGGGT
CAGTAGTGGATGAACACTTCTCAAGAGCTTTGGGCCAAGCCATCACCCTCCATCCAGAATCTGCCATTTCAAAAAGCAAGATGGGGCTAACCCCCCTATGGCGAGACAGCTCAGCTCTCTCAAGCCAG
CGGAATAGTTTCCCAACTTCCTTTTGGACCAGCTCTTACCAGCCCCCACCTGCACCTTGTTTGGGGGGAGTTCATCCTGACTTCCAGGTCACTGGACCCCCTGGCACCTTTTCTGCAGCTGATCCCAG
TCCTTGGCCGGGACACAACCTGCATCAGACTGGCCCAGCCCCTCCCCCTGCTGTGTCTGAGTCCTGGCCTTATCCTTTGACATCTCAGGTGAGCCCATCCTACAGCCATATGCATGACGTGTACATGC
GGCACCACCACCCTCATGCCCACATGCACCACCGCCACCGCCACCATCATCACCATCACCACCCTCCTGCTGGCTCTGCCCTGGATCCATCCTATGGGCCTCTGCTGATGCCTTCAGTGCATGCGGCC
AGGATTCCTGCTCCCCAGTGTGACATCACAAAGACAGAACCAACTACAGTCACCTCTGCTACCTCAGCATGGGCTGGAGCCTTTCATGGAACAGTAGACATAGTGCCCAGCGTGGGATTCGATACAGG
TCTACAGCATCAAGACAAGAGTAAGGAATCACCGTGGTACTGAAACACACAATCTTAGTGAGTTAAGTTGCAGCATAAATCCAAGGGCCCACTGGGAAAAGATACTGTCGGGTTTTTCCATTCAGCAA
TAGGACACGAAAGGCATAGAAGGAGAAGACAAAGTGTCACGCAGTTGACTGGTTTTCGGCCTTTCTTGAGAAAGCAAAGTGGGTCCCAGACATTGAAGAAAAGCATTTTTATTTGTTTATTTCCTCAT
CTGAGCCTTTGCCAACTGTGCAACTCTCTCCTTTTGTTATCTTGCTTTTATCAATATATAGCTAAGTTTTTGTTTCATTTTGATTTTTTTTTTTAGCCAACCACCTTGTCAGGAAAGGATGAACCACA
CATTAAAATGTTCATTCTTTCAGGAATACAAGTTTGTAGCTCTATGTGCATCTATTTTTGTAGAAATACAAAAAGTTTGGTTTAGCATTGATGGGCTATTTTTGAGGGATGTATTTTTTTTAAAATTG
TAAAAATTGTTGAGTTCTGTTTAAAGAACTTGCTCTCAGAGAAGCACTGGCAAAAATGTTTAAAATGCTTATCTCTAAGATGTCTATTATATGCTCTGTCTGTGCTTTCTAGGTTACCTCAAATGTTT
TGTTTTTTTCCTTCTTACAAAAGTAGCTATACCGTAGTCAAACCAATGCAGTATTGTTTTTACATTGAATCTCAGTAAAGATTTAATTCCATGCTAGCTCAATTAGTTTTGAATTATATGTATAGCTT
GAAAAGTTTTTTTTTAATGACTGTGCTAAAGAAATGATATTTTATTGCTTTGATTTCTCCCAAAGAATAACTTGGAGGTTGACTAATAAGAAAGTTGGCATAAACTTTCAATCAAATGAAGAGTTTGC
CTAGAGGAGACTAATTCTCTTTCTAGCCCATCCAAATTTGATAAATGGAACCAGAGGTTATATACAACTACAAGGAAAAAAATGCATTTAACCATGCCACCTATGAGTGCCAGTGACTTATTTTACTT
GTTTTTAATTATTCATTCATGGCAATTTAAAAAGTCATATTTTAAGTGGGATTTGTTTTTCCTGAAGGGCATTTGAAGGAACAATATCTGGGAAGGTACTAGAGAAATTACAAAGCCCGAGCTCTTTC
TTATAATGCCACCTATCCCTGTAAGCTAAACAAACAAACAAACAAACAAACAAACAGTTCTATATATAATAGTTTCAACACAGAACTTAACAAGTCTCTTTTTTTGTTTGTTTAAATCTGGCTTTACT
TGATTTAATTCCTTTTTAGAAAGAAATTTAGGGCAAAATAAAGTGTATATTAGGATTTAAATTTATGCCACAATTTAAAAATAAAACCAGAGGTTATATACAATTTAAATTGGGCTAAAAATTAAAAA
TTTGAGGATTTAACTTGATATAGCTCTCAGGATCTAAATAAAGTTTAAATTATCATTAAGACACTGCTAGGAGAAGATTAAGATTATGAAAGTAACAGTTATTGATACTGCTGGACTTCAAAGGCAAA
GTTCATTTCTTCCATTAACTGCTTCCAGAGATGTCATGTAAAAAAGTTAGTGTATTAGAGAAGTTTTTTAGCTTTATAAAGAGGTTTTTTCAAATTTCTCCCATTTTTCTCTCCACCCACATAAAATA
GTATGTTCAGTGAAATGCCACTTTCTATCTTTAATTGTTCGTATCATATATGCGAACTTTTTAGACATGAACATGACATGTTCAGCTAGGCAGAGTTCTCATAGATAATTTTCAAATATTTTCCTTGG
CTGTAATTTATGTATTCATTTATATCCTATCCGTCTTTTGAGCTTCAGATCTATATACTCTTTTGTACTCTCATCACTCCGCACTTTGCTGTTTCTTACCTAGACTCTCTTTTACACAATATGCACAT
TTTTACCATTGTGGGGTCCAAATTTAAGATACCTTCCACTCACTAATAATATGAACTTATATTTCCTGGGAGTAGCCAGGTTAAATTTTCTATACTTTGGTCCATAATTTGATTTGATATGATTGTTT
CATTTATAATTTGCCCAAATACATGGAGCACAAAATTTAGTGAATTTATAAATCTGGATTTGCCTTGTGTCCTTCTGAGTTTTCAAAGGCAAGTATTCAACAGTCCCTGTGTGATGACTGACAGGGTT
ATTTGCCTCATCCACATCCACCTTCGGAATACATTAACTTCCTTTGTAATTTATTTGAAAGTAGTGTTAAACTCATTCAGATCATTCAGTTGGATTTTCCCAATGAAGAGGAAAAGGAAAGTAGTTAT
TCCTAGCTCCATTTCTTATTTTCCACCAAATTTAATTGAAGGGCATTAATTAGATGTCTTCACCCTGAATTTAGACTTTGCTCTGTGTTCTCCCGGTAACTGTCAGACAAAAAGTTTATTGGCTCTGA
GGAACTGAGAAATGTTGGGAACCTGGTTTCTGCTGTACACAGGAAAGATTTGTAAGTGAGCTCTCTCTTTGAAAACAGGACCCAGGCTGGGCACAGCAGCTCATGCCTGTAATCCTAGTATTATAGGA
GGCAGAGGCTCGGGAGGATTGCTTGAGCCCAGGAGTTCAAGATCAGCCTAGGCAACATAGGGAGACCCTATCCCTACAAAAAATTTCTGAAAAATTACCTGGGCATTGTGGGGCACACCTGTTGTCCC
AGCTACTCTGGAGGCTGAGTCCGGAGGAACGTTTGAGCCTGGGAGTTTGAGTTTGCAGCTTGCAGTGAGCTGTGATTGCACCACTGTACTCCAGCTTGGGCAACAGAGCAAGATCCTGTCTCAAAAGG
AAAAAGAAAACAGGACCTAGGTGTTTGGGGTACACTGCCACCCAGGGAGTGGATCAAAAATATACATAGAAAGAGAATGAGCATGTCTCTATAATTGTCTTCTAGGACCATATTGCTGTTAGAAGTCC
TAAAAGAGGATGGGTTGTAATTTAGCATAATATTCTGAATTCATTCCAAGTTTAAAATCCTGTCATTCTCTGGCTCTTCTTTTTTCACATCAAAATGATGCTGTTGGACTTAGAGGCTTCCGAACTGT
TTTATTGAGGGCTACTATCTGCCTCCACAATTTTATTAAAACCACTCCACCTTTAGACAAAGGTGACTTTTGTCTGATTTTACAAATCAGATTTTATTCAAGCTTTCTAAATATCTGTGAAGTAGACC
CTAGAAAATTGTCTCGTTTATTTTAAATAGAATCTATGCTTCCACCAATAAACCATCGGGAGCTAAGAAACAACATAATGTTGACAAATCAGGAACCTAACAGATTATTTTGTCTCTCATTATTAATT
TGAAAGAGCCTCTAAACTTTTGAGAAATCAATGTGTCTTCTTAAGAAAGTTAAGCACCCTCTCTTAACTTTCCCCTCTATTTGCTCTCCTTTTTCTTTCTTCTTAAGAGTATTTATATTATTTTGTTA
AGCAAAAATGGCTAAGATTGCTCTAAAATTTGCAAAATGAGGAGTGGATTGCAAATAATTGAGGGATTTATTTCTTTAACTTTATAAGACTTTAAAAAAAAAACCCAAATTCTAAGCACTGACATGAA
AGTTGCCTTTGAGAAGCTTGTTATTCATTATACAAAAAGTATTTGCCCATTCCTATTCTAAGATTTGCAGAATATGTCACCCTATCTAGCTTTTGAGTTTGCTATCTGGTTTAATGTTGTATTTATAA
TTTAAAGTGGAAATCAGAAACTGTTTCAAGAACCTGTATTCTATTCCTTACTGAGTGTCCCTTCTTTAAATAGTGTTTGCTGAATTAAGCCGATGGGGGCAGTGGCGTTAAGTGGTGGAAAAAGGAAA
GTATATATGTTAGAGTTTTGAATGAGGGATAAATAGAAAGCAGAATGAATTAATGGAAAAGAACTCGGCTGTTAGGCCATTCTCTAAATTCTAGTTTAGCCAAAAGTTTATGTGTGGTTTGGGGCTTC
ATTTATTTATCTCATGAGTAAAATGGAATAATACCTAACAGGCAGGCTCTGGAAGTTGGAAATCACATACACACACACACACACACAGACACACACACACACGATCAATCATGTAGCTCATATTAGAT
GTTCAATAAATAACAGCTACTACAGATGCCTATCAGTTGAGTAAGTAGTTCATTAAATTGAGCTCCCAAAGGTCTCTTCTCTTCACATCCATATCCGTTTCTGCAGCAATCAAATAGATACATGATTG
TTTTTCTGTAAGAAATTACTGCAAAGAGAATCTTTTTCTCCTACTAACTGTTCCTTCTACCTGGTATAGGAGATAAATGTACGTTTCTTAATTAGCTGACTTTTTAGTATGTCATTTCTGAAGGAAAA
ATAAATTAACCTTAAAGTGGCATGTAGGTCCAATTCAGTTTTCCTACATGTTCCAAAATTTTATTTAAATTACTGTGTCCAAAATTATGAGGACAGTGTCATTCATTCACCATAGTTTATATTTTTAG
TTATATATCAAACTTCCTTGGCACCTAGGATAAGAACATTTCTTTTGAAGTTATCCAATTTTTTTTTATTTTTACTTGACTTGAAGGAAAGTTGGAAAATATGGTGGAAAAAATCTTCCGCATTAAAA
GGGGGAAAAACACAACCATTTACGATCTCAGTCAGCAGATTTACTCTACTCAAGGAAAAAAAGAAACAATCTTATTGGAAGCAGATGTTGACACTGTGTCAGTTATTGAAGACGGAAGGAGTTCACTT
GAGCCATTGCAGTTACAAAGGGGTATTGATGGCAGTTTGGATTCCTGATTGATCACCTTTGCAGCCAAGGGAAAGACAGCAGAAACTGTATGGGATCAGAAATGAAATCAGCCTGCCAGTTTAATGGA
GAGGCTCCTAGAAACTCATTTTTTTTCTTTCCTGTAAGATAAAAGACATCTTTCAGAATAAGAAAGGCTTGTTTGAGAGAGAAATTACAGTTTATTCTCTGAAAATATTTAAAGGCCAAAGTGCCCTT
TAAATCTATTATTAAAGCATTGAAACTGTTATTAAAATCATTATAGAAAAATTAGGTAAAAATTTTAGCCTAACTTTCAACATCCATTCAAAAACGAATGTTGAAAACAAACATATAACCTATAAAAA
AGTGAATGGCTCTGGCAAGTGGGGGCATGGGTGGAGTCCATAAGGAAACCTCAGTCTCAATAACTTCAAAATGTTACTTTTCATGGTAACTTGGTCATGGAGATTGGTCACAGCACAGACATTTAGAA
TTTTTTAGCAGGTTTTTTTTTTCTTTTGAATCTTGTAGTGCTCTCTGGGAATTGCACCATGTACACTTTTACAACCTACAGAAATCGTCATTATTGTTAAAGTATCTCAACTTTTCTATTTCTTTTAT
TGTCTATTGTGCTTTTTTGTTTAAAAATACTTTTATAGTTTTAAAGTATTGGTCAAAGTAGTATTCTCTTGAAGTTCTAGTCAATTTAATTTGATCCAATAAGTTTTTCTGAATCTCCTTTTTAAGTT
CCAAGAAATTCTATTATAAATAAGTGTACTTTTACCAATTCCATTGTATAAGCAAACAGACACCTTTTAGAAAAGGATAAGTAATCATCAATTTGTTTTTTTAAAAAAAAAAACAATTTCTAGACTAC
TAAATTTGGCATAAGAATAATTCTTTTAAAATGCAACATACTTTAATTAGTTTTTTTGGTATATGCATAAGATGTGAACTTTCCTATTGATATCACTTTATATTAATAGAGATGTACATTTCTTTCTA
TGCCGTGGCTAGAGCAAAAGTTAATAATGATTATTTACACAATTGATTTAATTTCTTAGGATATGTATAATATTGGATATTATATCTGATTTAAAAATACTATTCCATACATTTTTTTTTTCAGGAGA
TAAAACATAGGGAAAGGTTTTCATGTGAATTCTTTGTATCACTTTGAAGTACATATATTTAAAGGGAAGATGGATACAATTTGTTTTTATTATATAAATCTAGGTAAGGTGAAATGCTTTTGTCAACA
AAAATACAGTGTAGTGAATTTTATATTTGTCACTTGATTAGGTAAACTGAAAACTAACAATAGAAATATTATTTTACTGCATTGAAATACCATGAACTTTCAGACTTGTTAGTTCTACAAGAAGTTGT
GCTACCTTAATTTTGTGTTTCCAGAAATAAAAATTAACCTTAGTTATGCTGTCATTTTTAACTAATAAAAAAAGTATAATTCATAAAACTTTTGGCTTTATAAGATAATTATAAAATTATATATTTTT
TTCTGTTTTTGTGGGGTTGGGAAAACATTTTCTTATTTCTATTCACTCTTCAAATGCAGGTCTCATAATATGTGTCAATGATATAAGATGATGGAAGACTTTGTAATAAAAACATATGTCATTATCTT
CAATTTGTTCAATAAATAATTTAATGTGAATTGAATGTTTGTATTTTAACATAGCATTTGGATTTGGTCTGCATTTCTTGAGAATTTAAAGCTCTTTTTGTTTCCTCCTTATTCAATTAAGCATCTTA
TAAATATTTTGGAAATTACAACATCTTAGGTGTTATTAATTAAGAAGTTAATTTCTAGGGCCAAGAAGTCTATATGTTACAGCAAGGAATAGATTATAAAATACATGTTTATAATGGAAAAGAAAATG
AAATGGGGTATATTAATTACATAACAGCAAGAGTCTTGAGAATTTTATAATACAATGCTTCTAAGGATATTGGTTGACCAAGGTGTATTTTATTGTTTTTACATTTGTTGACAGGGACTCTGCCATAA
GTAGTATGAAAAAACAAACAAAAACTTTTCTACGATTCATTAACATTGAAAAGAGAATTCCAAGACCTTGTATTCTGAAGAAAGCTAGAGTTTCTCTAAGTGGGCCTTCAATTTTCTTATTACACGTA
TCTTTAATGTGAAAGTACTAAAGTCTGAAAATCAGCATTTAAATAATAGACTTTCCAGCATTACAGATGAAATAATTTGGCGCAGGCTTTTTAACTGTCTACCATATTTAGAATGTGGTGTCAAAATG
AGATTTTTAGAACTGCTGTAAAATATTACTACATTACTACAACGATAACGGCCTAAAACAACACAAATTTATTATCTTACAGCTCTGTCAGTCAGACATTCAGCAAAGATCTTAGTCTTGGTGGGCTA
CAGAATGTAGGAGGCATTTCCTGGATGCTTCCAAGAGAGAATCTTGCTGTTCCCTGCTTCTAGAGTCCTTTGCTTAGTTTCCTTCCATCTTCAAATCCAGCAACCTGGTCAAGACCTTCTCACATGAC
ATCACTGACTTCCTCTTCTTCCTCTCCCTTACATATTTAAGGACTCATGTGATTACAATAGCTGCATCTGTGTAATCCAGAATAATCTCTTCATCTCAAGGTTTTTGTTCTGTTTTGTTTTTTTGTTT
TGTTTTGTTTTGTTTTGTTTTGATGGAGTCTTGCTCTGTCGTCAGGCTGGAGTGCAGTGGCGCGATCTCGGCTCACTCCAACCTCCACCTCCCGGGTTCAAAGGATTCCCCTGCCTCAGCCTCTCGAG
TAGCTGGGACTACAGATGCGTGCTACCACACAAGGCTAATATTTTGTATTTTAGTAGAGACGGGATTTCACCATGTTGGCCAGGATGGTCTCCGTCTCCTGACCTCGTGATCTGCCTGCCTTGGCCTC
CCAAAGTGTTGGGATTACAGGCATAAGCCATTGCGCCATGCTCAAGGTTCTTAATTACATCTTTAAAGGCCCTTTTTCCATGTACAGTAACATATTCAATGGTTCTGGGGATTAGGACTTGGAGCCAT
TATTCTACCTACAACAATTAGTATTGGACTTCCATCATTTTCTATCACTCTTGTAATCGAGAAGGACTATTTCACTGGGAGTAGCAAGTCATAATGTTTGCGTTGGCATTTGTGTGGGGGTTTATCTT
CATTCATTAAATAATTGCATGTAAAGAAAATTCCTGTCACTATTTCAAATGTTTCATGTAGTTATTATAGTGCTTCAGAATCCAAAGGGTTATGTGTTACTTATGTAAGATGAGCAGTCTAGGGGGTG
GAGAACAGGTCATCTAGTGCAGATTCTTCCTAGCTGAAGTGTGTTTTCTCTGGGGACAACCAAGTAGGATTTAATTGTTTTGCTTCCTTTTTTGGGAACTTAGACCCATCTTGCGATGTCCTAAGTCT
CCAAGCATCTTATTTGACCTGCTTATACACATTTGACTAAATAGCTAAATATGACCACATTGACGTGGTAAAGCTTTAACACTTTTGTCCAGATTGAATCACTCCATCTGCTATCAGTTAAGCAGTGG
AAAACTGTTATGGAAAAGCAAACATGTTTTGATAGATTTAATGTGTAAAGAAGGTATCCATACTCTGGAATGCTGCTGATCAATAAATGAGCTGCAAGACTTTGTTCGAAACAACACTCAAGCACAAC
TGTTTTACTTTCCATACCAAGTTTGGCTGTGACTGAATGAAGAACATCAGCATTGATCTTTGCTTTGCACTTGTACAAGAGACTATTTGCAGAGAGCCAAATATAGCAACAGAGGATTTAATATCTTG
CCAAAAAATACAAAATCTGTTCCCCTTTAAGCATGACACTCTATCCTTTCTTGTGGATCTTGCTAAAAGGAAAATATAGCTTTAAACTCCCCTATTCCTTCTGTTGAAAGCTTAAGAATCTTTTTCAA
ATGAGCTATGTATGGTTTTGTGGTATTTTATGTTTCCAAAAGAAAATGGCTACATGAAAAATCTGTCCAGTGTTATCATTTTTCTTACAAAAAATACTTCTAGTTATGGTTGTATTAATTAATTTGAT
TGTGATAATGATTACACAATGTTTACCTATATCAAATCATCATATCGTATACCTTAAATATATATAACTTTTATGTGTCAATTATAACTCAGTAAGTCTGGGAAAATATCGTTAAGTCAAAGATTAGA
GTCAACAGAAATAAAGAAAAATCATACTTTGATAACTTCAGGACTAATCAAGGATCAATGGGTGACATGATATCATGCTATGTGCCATTTTGTGTTAAACAAATTACACCAACAATAAAAAAAATTGG
CTTCAA

hide sequence

RefSeq Acc Id:

XM_006713138 ⟹ XP_006713201

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	86,937,973 - 86,991,149 (-)	NCBI

Sequence:

show sequence

CTGCCCCGGCTGCCATGAGTTGTGCGGAGGTGATGTATCACCCCCAGCCTTATGGAGCGTCCCA
GTATCTGCCCAACCCCATGGCAGCGACAACCTGCCCCACAGCCTACTATCAGCCGGCGCCCCAACCTGGCCAGCAGAAGTTAGCGGTATTCAGCAAGATGCAGGACTCTCTGGAAGTCACCCTTCCCA
GCAAACAAGAGGAGGAGGATGAGGAGGAGGAGGAGGAGGAGAAAGACCAGCCTGCCGAGATGGAGTACCTTAACTCTCGCTGTGTCCTTTTCACTTATTTCCAGGGAGACATTGGGTCAGTAGTGGAT
GAACACTTCTCAAGAGCTTTGGGCCAAGCCATCACCCTCCATCCAGAATCTGCCATTTCAAAAAGCAAGATGGGGCTAACCCCCCTATGGCGAGACAGCTCAGCTCTCTCAAGCCAGCGGAATAGTTT
CCCAACTTCCTTTTGGACCAGCTCTTACCAGCCCCCACCTGCACCTTGTTTGGGGGGAGTTCATCCTGACTTCCAGGTCACTGGACCCCCTGGCACCTTTTCTGCAGCTGATCCCAGTCCTTGGCCGG
GACACAACCTGCATCAGACTGGCCCAGCCCCTCCCCCTGCTGTGTCTGAGTCCTGGCCTTATCCTTTGACATCTCAGGTGAGCCCATCCTACAGCCATATGCATGACGTGTACATGCGGCACCACCAC
CCTCATGCCCACATGCACCACCGCCACCGCCACCATCATCACCATCACCACCCTCCTGCTGGCTCTGCCCTGGATCCATCCTATGGGCCTCTGCTGATGCCTTCAGTGCATGCGGCCAGGATTCCTGC
TCCCCAGTGTGACATCACAAAGACAGAACCAACTACAGTCACCTCTGCTACCTCAGCATGGGCTGGAGCCTTTCATGGAACAGTAGACATAGTGCCCAGCGTGGGATTCGATACAGGTCTACAGCATC
AAGACAAGAGTAAGGAATCACCGTGGTACTGAAACACACAATCTTAGTGAGTTAAGTTGCAGCATAAATCCAAGGGCCCACTGGGAAAAGATACTGTCGGGTTTTTCCATTCAGCAATAGGACACGAA
AGGCATAGAAGGAGAAGACAAAGTGTCACGCAGTTGACTGGTTTTCGGCCTTTCTTGAGAAAGCAAAGTGGGTCCCAGACATTGAAGAAAAGCATTTTTATTTGTTTATTTCCTCATCTGAGCCTTTG
CCAACTGTGCAACTCTCTCCTTTTGTTATCTTGCTTTTATCAATATATAGCTAAGTTTTTGTTTCATTTTGATTTTTTTTTTTAGCCAACCACCTTGTCAGGAAAGGATGAACCACACATTAAAATGT
TCATTCTTTCAGGAATACAAGTTTGTAGCTCTATGTGCATCTATTTTTGTAGAAATACAAAAAGTTTGGTTTAGCATTGATGGGCTATTTTTGAGGGATGTATTTTTTTTAAAATTGTAAAAATTGTT
GAGTTCTGTTTAAAGAACTTGCTCTCAGAGAAGCACTGGCAAAAATGTTTAAAATGCTTATCTCTAAGATGTCTATTATATGCTCTGTCTGTGCTTTCTAGGTTACCTCAAATGTTTTGTTTTTTTCC
TTCTTACAAAAGTAGCTATACCGTAGTCAAACCAATGCAGTATTGTTTTTACATTGAATCTCAGTAAAGATTTAATTCCATGCTAGCTCAATTAGTTTTGAATTATATGTATAGCTTGAAAAGTTTTT
TTTTAATGACTGTGCTAAAGAAATGATATTTTATTGCTTTGATTTCTCCCAAAGAATAACTTGGAGGTTGACTAATAAGAAAGTTGGCATAAACTTTCAATCAAATGAAGAGTTTGCCTAGAGGAGAC
TAATTCTCTTTCTAGCCCATCCAAATTTGATAAATGGAACCAGAGGTTATATACAACTACAAGGAAAAAAATGCATTTAACCATGCCACCTATGAGTGCCAGTGACTTATTTTACTTGTTTTTAATTA
TTCATTCATGGCAATTTAAAAAGTCATATTTTAAGTGGGATTTGTTTTTCCTGAAGGGCATTTGAAGGAACAATATCTGGGAAGGTACTAGAGAAATTACAAAGCCCGAGCTCTTTCTTATAATGCCA
CCTATCCCTGTAAGCTAAACAAACAAACAAACAAACAAACAAACAGTTCTATATATAATAGTTTCAACACAGAACTTAACAAGTCTCTTTTTTTGTTTGTTTAAATCTGGCTTTACTTGATTTAATTC
CTTTTTAGAAAGAAATTTAGGGCAAAATAAAGTGTATATTAGGATTTAAATTTATGCCACAATTTAAAAATAAAACCAGAGGTTATATACAATTTAAATTGGGCTAAAAATTAAAAATTTGAGGATTT
AACTTGATATAGCTCTCAGGATCTAAATAAAGTTTAAATTATCATTAAGACACTGCTAGGAGAAGATTAAGATTATGAAAGTAACAGTTATTGATACTGCTGGACTTCAAAGGCAAAGTTCATTTCTT
CCATTAACTGCTTCCAGAGATGTCATGTAAAAAAGTTAGTGTATTAGAGAAGTTTTTTAGCTTTATAAAGAGGTTTTTTCAAATTTCTCCCATTTTTCTCTCCACCCACATAAAATAGTATGTTCAGT
GAAATGCCACTTTCTATCTTTAATTGTTCGTATCATATATGCGAACTTTTTAGACATGAACATGACATGTTCAGCTAGGCAGAGTTCTCATAGATAATTTTCAAATATTTTCCTTGGCTGTAATTTAT
GTATTCATTTATATCCTATCCGTCTTTTGAGCTTCAGATCTATATACTCTTTTGTACTCTCATCACTCCGCACTTTGCTGTTTCTTACCTAGACTCTCTTTTACACAATATGCACATTTTTACCATTG
TGGGGTCCAAATTTAAGATACCTTCCACTCACTAATAATATGAACTTATATTTCCTGGGAGTAGCCAGGTTAAATTTTCTATACTTTGGTCCATAATTTGATTTGATATGATTGTTTCATTTATAATT
TGCCCAAATACATGGAGCACAAAATTTAGTGAATTTATAAATCTGGATTTGCCTTGTGTCCTTCTGAGTTTTCAAAGGCAAGTATTCAACAGTCCCTGTGTGATGACTGACAGGGTTATTTGCCTCAT
CCACATCCACCTTCGGAATACATTAACTTCCTTTGTAATTTATTTGAAAGTAGTGTTAAACTCATTCAGATCATTCAGTTGGATTTTCCCAATGAAGAGGAAAAGGAAAGTAGTTATTCCTAGCTCCA
TTTCTTATTTTCCACCAAATTTAATTGAAGGGCATTAATTAGATGTCTTCACCCTGAATTTAGACTTTGCTCTGTGTTCTCCCGGTAACTGTCAGACAAAAAGTTTATTGGCTCTGAGGAACTGAGAA
ATGTTGGGAACCTGGTTTCTGCTGTACACAGGAAAGATTTGTAAGTGAGCTCTCTCTTTGAAAACAGGACCCAGGCTGGGCACAGCAGCTCATGCCTGTAATCCTAGTATTATAGGAGGCAGAGGCTC
GGGAGGATTGCTTGAGCCCAGGAGTTCAAGATCAGCCTAGGCAACATAGGGAGACCCTATCCCTACAAAAAATTTCTGAAAAATTACCTGGGCATTGTGGGGCACACCTGTTGTCCCAGCTACTCTGG
AGGCTGAGTCCGGAGGAACGTTTGAGCCTGGGAGTTTGAGTTTGCAGCTTGCAGTGAGCTGTGATTGCACCACTGTACTCCAGCTTGGGCAACAGAGCAAGATCCTGTCTCAAAAGGAAAAAGAAAAC
AGGACCTAGGTGTTTGGGGTACACTGCCACCCAGGGAGTGGATCAAAAATATACATAGAAAGAGAATGAGCATGTCTCTATAATTGTCTTCTAGGACCATATTGCTGTTAGAAGTCCTAAAAGAGGAT
GGGTTGTAATTTAGCATAATATTCTGAATTCATTCCAAGTTTAAAATCCTGTCATTCTCTGGCTCTTCTTTTTTCACATCAAAATGATGCTGTTGGACTTAGAGGCTTCCGAACTGTTTTATTGAGGG
CTACTATCTGCCTCCACAATTTTATTAAAACCACTCCACCTTTAGACAAAGGTGACTTTTGTCTGATTTTACAAATCAGATTTTATTCAAGCTTTCTAAATATCTGTGAAGTAGACCCTAGAAAATTG
TCTCGTTTATTTTAAATAGAATCTATGCTTCCACCAATAAACCATCGGGAGCTAAGAAACAACATAATGTTGACAAATCAGGAACCTAACAGATTATTTTGTCTCTCATTATTAATTTGAAAGAGCCT
CTAAACTTTTGAGAAATCAATGTGTCTTCTTAAGAAAGTTAAGCACCCTCTCTTAACTTTCCCCTCTATTTGCTCTCCTTTTTCTTTCTTCTTAAGAGTATTTATATTATTTTGTTAAGCAAAAATGG
CTAAGATTGCTCTAAAATTTGCAAAATGAGGAGTGGATTGCAAATAATTGAGGGATTTATTTCTTTAACTTTATAAGACTTTAAAAAAAAAACCCAAATTCTAAGCACTGACATGAAAGTTGCCTTTG
AGAAGCTTGTTATTCATTATACAAAAAGTATTTGCCCATTCCTATTCTAAGATTTGCAGAATATGTCACCCTATCTAGCTTTTGAGTTTGCTATCTGGTTTAATGTTGTATTTATAATTTAAAGTGGA
AATCAGAAACTGTTTCAAGAACCTGTATTCTATTCCTTACTGAGTGTCCCTTCTTTAAATAGTGTTTGCTGAATTAAGCCGATGGGGGCAGTGGCGTTAAGTGGTGGAAAAAGGAAAGTATATATGTT
AGAGTTTTGAATGAGGGATAAATAGAAAGCAGAATGAATTAATGGAAAAGAACTCGGCTGTTAGGCCATTCTCTAAATTCTAGTTTAGCCAAAAGTTTATGTGTGGTTTGGGGCTTCATTTATTTATC
TCATGAGTAAAATGGAATAATACCTAACAGGCAGGCTCTGGAAGTTGGAAATCACATACACACACACACACACACAGACACACACACACACGATCAATCATGTAGCTCATATTAGATGTTCAATAAAT
AACAGCTACTACAGATGCCTATCAGTTGAGTAAGTAGTTCATTAAATTGAGCTCCCAAAGGTCTCTTCTCTTCACATCCATATCCGTTTCTGCAGCAATCAAATAGATACATGATTGTTTTTCTGTAA
GAAATTACTGCAAAGAGAATCTTTTTCTCCTACTAACTGTTCCTTCTACCTGGTATAGGAGATAAATGTACGTTTCTTAATTAGCTGACTTTTTAGTATGTCATTTCTGAAGGAAAAATAAATTAACC
TTAAAGTGGCATGTAGGTCCAATTCAGTTTTCCTACATGTTCCAAAATTTTATTTAAATTACTGTGTCCAAAATTATGAGGACAGTGTCATTCATTCACCATAGTTTATATTTTTAGTTATATATCAA
ACTTCCTTGGCACCTAGGATAAGAACATTTCTTTTGAAGTTATCCAATTTTTTTTTATTTTTACTTGACTTGAAGGAAAGTTGGAAAATATGGTGGAAAAAATCTTCCGCATTAAAAGGGGGAAAAAC
ACAACCATTTACGATCTCAGTCAGCAGATTTACTCTACTCAAGGAAAAAAAGAAACAATCTTATTGGAAGCAGATGTTGACACTGTGTCAGTTATTGAAGACGGAAGGAGTTCACTTGAGCCATTGCA
GTTACAAAGGGGTATTGATGGCAGTTTGGATTCCTGATTGATCACCTTTGCAGCCAAGGGAAAGACAGCAGAAACTGTATGGGATCAGAAATGAAATCAGCCTGCCAGTTTAATGGAGAGGCTCCTAG
AAACTCATTTTTTTTCTTTCCTGTAAGATAAAAGACATCTTTCAGAATAAGAAAGGCTTGTTTGAGAGAGAAATTACAGTTTATTCTCTGAAAATATTTAAAGGCCAAAGTGCCCTTTAAATCTATTA
TTAAAGCATTGAAACTGTTATTAAAATCATTATAGAAAAATTAGGTAAAAATTTTAGCCTAACTTTCAACATCCATTCAAAAACGAATGTTGAAAACAAACATATAACCTATAAAAAAGTGAATGGCT
CTGGCAAGTGGGGGCATGGGTGGAGTCCATAAGGAAACCTCAGTCTCAATAACTTCAAAATGTTACTTTTCATGGTAACTTGGTCATGGAGATTGGTCACAGCACAGACATTTAGAATTTTTTAGCAG
GTTTTTTTTTTCTTTTGAATCTTGTAGTGCTCTCTGGGAATTGCACCATGTACACTTTTACAACCTACAGAAATCGTCATTATTGTTAAAGTATCTCAACTTTTCTATTTCTTTTATTGTCTATTGTG
CTTTTTTGTTTAAAAATACTTTTATAGTTTTAAAGTATTGGTCAAAGTAGTATTCTCTTGAAGTTCTAGTCAATTTAATTTGATCCAATAAGTTTTTCTGAATCTCCTTTTTAAGTTCCAAGAAATTC
TATTATAAATAAGTGTACTTTTACCAATTCCATTGTATAAGCAAACAGACACCTTTTAGAAAAGGATAAGTAATCATCAATTTGTTTTTTTAAAAAAAAAAACAATTTCTAGACTACTAAATTTGGCA
TAAGAATAATTCTTTTAAAATGCAACATACTTTAATTAGTTTTTTTGGTATATGCATAAGATGTGAACTTTCCTATTGATATCACTTTATATTAATAGAGATGTACATTTCTTTCTATGCCGTGGCTA
GAGCAAAAGTTAATAATGATTATTTACACAATTGATTTAATTTCTTAGGATATGTATAATATTGGATATTATATCTGATTTAAAAATACTATTCCATACATTTTTTTTTTCAGGAGATAAAACATAGG
GAAAGGTTTTCATGTGAATTCTTTGTATCACTTTGAAGTACATATATTTAAAGGGAAGATGGATACAATTTGTTTTTATTATATAAATCTAGGTAAGGTGAAATGCTTTTGTCAACAAAAATACAGTG
TAGTGAATTTTATATTTGTCACTTGATTAGGTAAACTGAAAACTAACAATAGAAATATTATTTTACTGCATTGAAATACCATGAACTTTCAGACTTGTTAGTTCTACAAGAAGTTGTGCTACCTTAAT
TTTGTGTTTCCAGAAATAAAAATTAACCTTAGTTATGCTGTCATTTTTAACTAATAAAAAAAGTATAATTCATAAAACTTTTGGCTTTATAAGATAATTATAAAATTATATATTTTTTTCTGTTTTTG
TGGGGTTGGGAAAACATTTTCTTATTTCTATTCACTCTTCAAATGCAGGTCTCATAATATGTGTCAATGATATAAGATGATGGAAGACTTTGTAATAAAAACATATGTCATTATCTTCAATTTGTTCA
ATAAATAATTTAATGTGAATTGAATGTTTGTATTTTAACATAGCATTTGGATTTGGTCTGCATTTCTTGAGAATTTAAAGCTCTTTTTGTTTCCTCCTTATTCAATTAAGCATCTTATAAATATTTTG
GAAATTACAACATCTTAGGTGTTATTAATTAAGAAGTTAATTTCTAGGGCCAAGAAGTCTATATGTTACAGCAAGGAATAGATTATAAAATACATGTTTATAATGGAAAAGAAAATGAAATGGGGTAT
ATTAATTACATAACAGCAAGAGTCTTGAGAATTTTATAATACAATGCTTCTAAGGATATTGGTTGACCAAGGTGTATTTTATTGTTTTTACATTTGTTGACAGGGACTCTGCCATAAGTAGTATGAAA
AAACAAACAAAAACTTTTCTACGATTCATTAACATTGAAAAGAGAATTCCAAGACCTTGTATTCTGAAGAAAGCTAGAGTTTCTCTAAGTGGGCCTTCAATTTTCTTATTACACGTATCTTTAATGTG
AAAGTACTAAAGTCTGAAAATCAGCATTTAAATAATAGACTTTCCAGCATTACAGATGAAATAATTTGGCGCAGGCTTTTTAACTGTCTACCATATTTAGAATGTGGTGTCAAAATGAGATTTTTAGA
ACTGCTGTAAAATATTACTACATTACTACAACGATAACGGCCTAAAACAACACAAATTTATTATCTTACAGCTCTGTCAGTCAGACATTCAGCAAAGATCTTAGTCTTGGTGGGCTACAGAATGTAGG
AGGCATTTCCTGGATGCTTCCAAGAGAGAATCTTGCTGTTCCCTGCTTCTAGAGTCCTTTGCTTAGTTTCCTTCCATCTTCAAATCCAGCAACCTGGTCAAGACCTTCTCACATGACATCACTGACTT
CCTCTTCTTCCTCTCCCTTACATATTTAAGGACTCATGTGATTACAATAGCTGCATCTGTGTAATCCAGAATAATCTCTTCATCTCAAGGTTTTTGTTCTGTTTTGTTTTTTTGTTTTGTTTTGTTTT
GTTTTGTTTTGATGGAGTCTTGCTCTGTCGTCAGGCTGGAGTGCAGTGGCGCGATCTCGGCTCACTCCAACCTCCACCTCCCGGGTTCAAAGGATTCCCCTGCCTCAGCCTCTCGAGTAGCTGGGACT
ACAGATGCGTGCTACCACACAAGGCTAATATTTTGTATTTTAGTAGAGACGGGATTTCACCATGTTGGCCAGGATGGTCTCCGTCTCCTGACCTCGTGATCTGCCTGCCTTGGCCTCCCAAAGTGTTG
GGATTACAGGCATAAGCCATTGCGCCATGCTCAAGGTTCTTAATTACATCTTTAAAGGCCCTTTTTCCATGTACAGTAACATATTCAATGGTTCTGGGGATTAGGACTTGGAGCCATTATTCTACCTA
CAACAATTAGTATTGGACTTCCATCATTTTCTATCACTCTTGTAATCGAGAAGGACTATTTCACTGGGAGTAGCAAGTCATAATGTTTGCGTTGGCATTTGTGTGGGGGTTTATCTTCATTCATTAAA
TAATTGCATGTAAAGAAAATTCCTGTCACTATTTCAAATGTTTCATGTAGTTATTATAGTGCTTCAGAATCCAAAGGGTTATGTGTTACTTATGTAAGATGAGCAGTCTAGGGGGTGGAGAACAGGTC
ATCTAGTGCAGATTCTTCCTAGCTGAAGTGTGTTTTCTCTGGGGACAACCAAGTAGGATTTAATTGTTTTGCTTCCTTTTTTGGGAACTTAGACCCATCTTGCGATGTCCTAAGTCTCCAAGCATCTT
ATTTGACCTGCTTATACACATTTGACTAAATAGCTAAATATGACCACATTGACGTGGTAAAGCTTTAACACTTTTGTCCAGATTGAATCACTCCATCTGCTATCAGTTAAGCAGTGGAAAACTGTTAT
GGAAAAGCAAACATGTTTTGATAGATTTAATGTGTAAAGAAGGTATCCATACTCTGGAATGCTGCTGATCAATAAATGAGCTGCAAGACTTTGTTCGAAACAACACTCAAGCACAACTGTTTTACTTT
CCATACCAAGTTTGGCTGTGACTGAATGAAGAACATCAGCATTGATCTTTGCTTTGCACTTGTACAAGAGACTATTTGCAGAGAGCCAAATATAGCAACAGAGGATTTAATATCTTGCCAAAAAATAC
AAAATCTGTTCCCCTTTAAGCATGACACTCTATCCTTTCTTGTGGATCTTGCTAAAAGGAAAATATAGCTTTAAACTCCCCTATTCCTTCTGTTGAAAGCTTAAGAATCTTTTTCAAATGAGCTATGT
ATGGTTTTGTGGTATTTTATGTTTCCAAAAGAAAATGGCTACATGAAAAATCTGTCCAGTGTTATCATTTTTCTTACAAAAAATACTTCTAGTTATGGTTGTATTAATTAATTTGATTGTGATAATGA
TTACACAATGTTTACCTATATCAAATCATCATATCGTATACCTTAAATATATATAACTTTTATGTGTCAATTATAACTCAGTAAGTCTGGGAAAATATCGTTAAGTCAAAGATTAGAGTCAACAGAAA
TAAAGAAAAATCATACTTTGATAACTTCAGGACTAATCAAGGATCAATGGGTGACATGATATCATGCTATGTGCCATTTTGTGTTAAACAAATTACACCAACAATAAAAAAAATTGGCTTCAA

hide sequence

RefSeq Acc Id:

XM_054346475 ⟹ XP_054202450

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	3	87,012,305 - 87,065,510 (-)	NCBI


Protein RefSeqs	NP_001307422	(Get FASTA)	NCBI Sequence Viewer
	NP_001307423	(Get FASTA)	NCBI Sequence Viewer
	NP_057290	(Get FASTA)	NCBI Sequence Viewer
	XP_006713201	(Get FASTA)	NCBI Sequence Viewer
	XP_054202450	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	A8MV65	(Get FASTA)	NCBI Sequence Viewer
	AAF00091	(Get FASTA)	NCBI Sequence Viewer
	AAH94780	(Get FASTA)	NCBI Sequence Viewer
	CBX78569	(Get FASTA)	NCBI Sequence Viewer
	CBX78571	(Get FASTA)	NCBI Sequence Viewer
	CBX87123	(Get FASTA)	NCBI Sequence Viewer
	CBX87124	(Get FASTA)	NCBI Sequence Viewer
	EAW68870	(Get FASTA)	NCBI Sequence Viewer
	EAW68871	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000373199
	ENSP00000373199.3
	ENSP00000381436
	ENSP00000381436.2

RefSeq Acc Id:	NP_057290 ⟸ NM_016206
- Peptide Label:	isoform 1
- UniProtKB:	D3DU37 (UniProtKB/Swiss-Prot), Q504T7 (UniProtKB/Swiss-Prot), A8MV65 (UniProtKB/Swiss-Prot)
- Sequence:	show sequence MSCAEVMYHPQPYGASQYLPNPMAATTCPTAYYQPAPQPGQQKKLAVFSKMQDSLEVTLPSKQEEEDEEEEEEEKDQPAEMEYLNSRCVLFTYFQGDIGSVVDEHFSRALGQAITLHPESAISKSKMG LTPLWRDSSALSSQRNSFPTSFWTSSYQPPPAPCLGGVHPDFQVTGPPGTFSAADPSPWPGHNLHQTGPAPPPAVSESWPYPLTSQVSPSYSHMHDVYMRHHHPHAHMHHRHRHHHHHHHPPAGSALD PSYGPLLMPSVHAARIPAPQCDITKTEPTTVTSATSAWAGAFHGTVDIVPSVGFDTGLQHQDKSKESPWY hide sequence

RefSeq Acc Id:

XP_006713201 ⟸ XM_006713138

- Peptide Label:

isoform X1

- Sequence:

show sequence

MSCAEVMYHPQPYGASQYLPNPMAATTCPTAYYQPAPQPGQQKLAVFSKMQDSLEVTLPSKQEEEDEEEEEEEKDQPAEMEYLNSRCVLFTYFQGDIGSVVDEHFSRALGQAITLHPESAISKSKMGL
TPLWRDSSALSSQRNSFPTSFWTSSYQPPPAPCLGGVHPDFQVTGPPGTFSAADPSPWPGHNLHQTGPAPPPAVSESWPYPLTSQVSPSYSHMHDVYMRHHHPHAHMHHRHRHHHHHHHPPAGSALDP
SYGPLLMPSVHAARIPAPQCDITKTEPTTVTSATSAWAGAFHGTVDIVPSVGFDTGLQHQDKSKESPWY

hide sequence

RefSeq Acc Id:

NP_001307423 ⟸ NM_001320494

- Peptide Label:

isoform 3

- Sequence:

show sequence

MSCAEVMYHPQPYGASQYLPNPMAATTCPTAYYQPAPQPGQQGDIGSVVDEHFSRALGQAITLHPESAISKSKMGLTPLWRDSSALSSQRNSFPTSFWTSSYQPPPAPCLGGVHPDFQVTGPPGTFSA
ADPSPWPGHNLHQTGPAPPPAVSESWPYPLTSQVSPSYSHMHDVYMRHHHPHAHMHHRHRHHHHHHHPPAGSALDPSYGPLLMPSVHAARIPAPQCDITKTEPTTVTSATSAWAGAFHGTVDIVPSVG
FDTGLQHQDKSKESPWY

hide sequence

RefSeq Acc Id:	NP_001307422 ⟸ NM_001320493
- Peptide Label:	isoform 2
- UniProtKB:	A8MV65 (UniProtKB/Swiss-Prot)
- Sequence:	show sequence MSCAEVMYHPQPYGASQYLPNPMAATTCPTAYYQPAPQPGQQKKLAVFSKMQDSLEVTLPSKQE EEDEEEEEEEKDQPAEMEYLNSRCVLFTYFQGDIGSVVDEHFSRALGQAITLHPESAISKSKMGLTPLWRDSSALSSQRNSFPTSFWTSSYQPPPAPCLGGVHPDFQVTGPPGTFSAADPSPWPGHNL HQTGPAPPPAVSESWPYPLTSQVSPSYSHMHDVYMRHHHPHAHMHHRHRHHHHHHHPPAGSALDPSYGPLLMPSVHAARIPAPQCDITKTEPTTVTSATSAWAGAFHGTVDIVPSVGFDTGWSAMARS hide sequence

Ensembl Acc Id:

ENSP00000381436 ⟸ ENST00000398399

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-A8MV65-F1-model_v2	AlphaFold	A8MV65	1-326	view protein structure

RGD ID:

6865026

Promoter ID:

EPDNEW_H5678

Type:

initiation region

Name:

VGLL3_2

Description:

vestigial like family member 3

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H5679

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	86,990,860 - 86,990,920	EPDNEW

RGD ID:

6865028

Promoter ID:

EPDNEW_H5679

Type:

initiation region

Name:

VGLL3_1

Description:

vestigial like family member 3

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H5678

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	3	86,991,121 - 86,991,181	EPDNEW

RGD ID:

6800985

Promoter ID:

HG_KWN:45593

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

HeLa_S3

Transcripts:

ENST00000383698, NM_016206

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	3	87,122,546 - 87,123,046 (-)	MPROMDB

Database	Acc Id	Source(s)
COSMIC	VGLL3	COSMIC
Ensembl Genes	ENSG00000206538	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000383698	ENTREZGENE
	ENST00000383698.3	UniProtKB/Swiss-Prot
	ENST00000398399	ENTREZGENE
	ENST00000398399.7	UniProtKB/Swiss-Prot
GTEx	ENSG00000206538	GTEx
HGNC ID	HGNC:24327	ENTREZGENE
Human Proteome Map	VGLL3	Human Proteome Map
InterPro	TDU_repeat	UniProtKB/Swiss-Prot
	Vg_fam	UniProtKB/Swiss-Prot
KEGG Report	hsa:389136	UniProtKB/Swiss-Prot
NCBI Gene	389136	ENTREZGENE
OMIM	609980	OMIM
PANTHER	PTHR15950	UniProtKB/Swiss-Prot
	TRANSCRIPTION COFACTOR VESTIGIAL-LIKE PROTEIN 3	UniProtKB/Swiss-Prot
Pfam	Vg_Tdu	UniProtKB/Swiss-Prot
PharmGKB	PA142670628	PharmGKB
SMART	TDU	UniProtKB/Swiss-Prot
UniProt	A0A1B0GTF5_HUMAN	UniProtKB/TrEMBL
	A8MV65	ENTREZGENE
	D3DU37	ENTREZGENE
	H7C571_HUMAN	UniProtKB/TrEMBL
	Q504T7	ENTREZGENE
	VGLL3_HUMAN	UniProtKB/Swiss-Prot
UniProt Secondary	D3DU37	UniProtKB/Swiss-Prot
	Q504T7	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2015-12-01	VGLL3	vestigial like family member 3		vestigial-like family member 3	Symbol and/or name change	5135510	APPROVED
2014-03-05	VGLL3	vestigial-like family member 3		vestigial like 3 (Drosophila)	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Send us a Message